WO2013153812A1 - Agitating injection device - Google Patents

Agitating injection device Download PDF

Info

Publication number
WO2013153812A1
WO2013153812A1 PCT/JP2013/002458 JP2013002458W WO2013153812A1 WO 2013153812 A1 WO2013153812 A1 WO 2013153812A1 JP 2013002458 W JP2013002458 W JP 2013002458W WO 2013153812 A1 WO2013153812 A1 WO 2013153812A1
Authority
WO
WIPO (PCT)
Prior art keywords
syringe
unit
holding unit
injection device
stirring
Prior art date
Application number
PCT/JP2013/002458
Other languages
French (fr)
Japanese (ja)
Inventor
根本 茂
Original Assignee
株式会社根本杏林堂
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社根本杏林堂 filed Critical 株式会社根本杏林堂
Priority to JP2014510058A priority Critical patent/JP6463628B2/en
Priority to CN201380019290.8A priority patent/CN104220110A/en
Publication of WO2013153812A1 publication Critical patent/WO2013153812A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/1456Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/1458Means for capture of the plunger flange

Definitions

  • the present invention relates to an injection device for injecting a chemical solution, and relates to an injection device for stirring for stirring the chemical solution in a mounted syringe.
  • a contrast medium made of a suspension as a chemical solution used for imaging by a medical imaging apparatus, for example, an ultrasonic diagnostic apparatus.
  • This contrast agent contains microbubbles, solid particles and the like in order to scatter ultrasonic waves.
  • a syringe filled with the contrast agent is attached to an injection device, and imaging is performed after the contrast agent is injected into the patient's body.
  • the ultrasonic diagnostic apparatus captures an image of the inside of a body by analyzing ultrasonic waves that are incident on and reflected by microbubbles or solid particles.
  • the contrast agent may be separated, and the concentration of the contrast agent content may be biased.
  • Patent Document 1 discloses an injection system for maintaining the suspension in the syringe of the injection device in a sufficiently stirred state.
  • the injection system is an injection system for treating a patient by injecting a suspension of microparticles in an aqueous liquid carrier.
  • the injection system consists of a syringe capable of filling the barrel with suspension and automatic electric drive means that controllably move to inject the suspension into the patient.
  • the injection system also has a stirring means for holding the syringe in the system and stirring the fine particles in the suspension. This stirring means maintains the uniformity of the suspension by preventing the separation of the fine particles due to gravity or buoyancy by the movement given to the syringe.
  • Patent Document 1 discloses a roller that is in contact with a syringe barrel in order to give continuous rotation to the syringe barrel as a stirring means.
  • the roller holds the syringe disposed on the roller and rotates the held syringe. Thereby, the roller can stir the suspension in the barrel of the syringe.
  • Patent Document 1 discloses two brackets that support a syringe in a rotatable manner as stirring means. These brackets hold the syringe and rotate the syringe. Thereby, the bracket stirs the suspension in the barrel of the syringe.
  • Patent Document 1 has the following problems. That is, when a syringe is held by being placed on a roller, the syringe is likely to be displaced and may be detached from the injection device. In addition, when injecting, in order to prevent injecting air into the patient, the syringe is mounted with the syringe mounting side (the syringe tip side) facing the floor surface. Sometimes. In this case, the syringe placed on the roller shifts due to gravity and comes off the injection device.
  • the held syringe is easily detached. That is, since the syringe is rotatably held, the syringe cannot be fixed to the blanket that is also a holding means. Furthermore, since it is necessary to observe the chemical solution from the outside, it is difficult to provide a member that covers the upper surface of the syringe in order to fix the syringe. Therefore, also when hold
  • the posture of the syringe may be tilted in the injection device. And if the attitude
  • the syringe is held by stirring means. Therefore, the size or shape of the syringe that can be held is limited to the size or shape that the stirring means can accommodate. And in order to mount
  • an injection device for agitation is an injection device for injecting a chemical solution, the first drive unit for extruding the first chemical solution from a first syringe filled with the first chemical solution, A first holding unit that fixes and holds the first syringe, a support member that supports the first holding unit, and the first drug solution in the first syringe are agitated while being connected to the first holding unit. And a stirring unit for moving the first holding unit.
  • the stirring injection device of the present invention is an injection device for injecting a chemical solution, a drive unit for pushing out the chemical solution from a syringe filled with the chemical solution, a holding unit for fixing and holding the syringe, and the holding device A support member that supports the unit, and a stirring unit that contacts the outer surface of the syringe at a position spaced from the holding unit and moves the syringe in order to stir the drug solution in the syringe.
  • the syringe is fixed to and held by the holding unit. Therefore, even if the tip end side of the syringe is directed to the floor surface, it is possible to prevent the syringe from shifting during the stirring operation.
  • the chemical solution can be agitated while maintaining the tip portion of the syringe in a clean state.
  • syringes of various sizes or shapes can be attached to the stirring injection device.
  • FIG. 1 shows an injection device (injector) 100 used when a patient's body is imaged by a medical imaging device, for example, an ultrasonic diagnostic device, and a stand 2 that holds an injector head 1 that is a head portion of the injection device.
  • a medical imaging device for example, an ultrasonic diagnostic device
  • the stand 2 has a movable stand base placed on the floor and a stand pole on the stand base.
  • the injector head 1 is held on the top or side of the stand pole.
  • the injector head 1 is held by a stand pole so as to be rotatable in the left-right direction or the up-down direction.
  • the injector head 1 has a posture in which the tip side (side where the syringe is mounted) of the injector head 1 is directed to the floor surface, and the rear end side (side where the syringe is not mounted) of the injector head 1 is the floor surface. It can be rotated to the direction it faces.
  • FIG. 1 shows a state in which a syringe is attached to the injector head 1 and preparations for injecting a chemical solution are ready. Therefore, the injector head 1 is inclined so that the tip side of the injector head 1 faces the floor surface.
  • the injector 100 that injects the chemical solution injects a contrast agent as the first chemical solution and physiological saline as the second chemical solution into the patient. Therefore, as shown in FIG. 2, the injector head 1 fixes the first holding unit 11 for fixing and holding the first syringe 4 filled with the contrast agent, and the second syringe 5 filled with physiological saline. And a second holding unit 12 for holding, and a support arm 14 as a support member for supporting the first holding unit 11 and the second holding unit 12.
  • the internal mechanisms of the first holding unit 11 and the second holding unit 12 are accommodated in the covers of the first holding unit 11 and the second holding unit 12. Further, the injector head 1 includes a stirring unit 13 connected to the first holding unit 11.
  • the internal mechanism of the stirring unit 13 is accommodated in the cover of the stirring unit 13. Then, the stirring unit 13 moves the first holding unit 11 in order to stir the contrast agent in the first syringe 4.
  • the first drive unit 16 that pushes out the contrast agent from the first syringe 4 is provided in the first holding unit 11.
  • a second drive unit 17 that pushes physiological saline from the second syringe 5 is provided in the second holding unit 12.
  • the first holding unit 11 has a syringe adapter 6.
  • the first syringe 4 is fixed to the first holding unit 11 by holding the cylinder flange 41 of the first syringe 4 on the syringe adapter 6. Thereby, it can prevent that the 1st syringe 4 shifts
  • the cylinder flange 51 of the second syringe 5 is held by the syringe adapter 6 provided on the support arm 14. Thereby, the second syringe 5 is held by the second holding unit 12.
  • These syringe adapters 6 have a recess, and the cylinder flanges 41 and 51 are inserted into the recess. Therefore, attachment and removal of the first syringe 4 and the second syringe 5 are very easy.
  • the syringe adapter 6 is detachably attached to the first holding unit 11 or the support arm 14. And the syringe adapter 6 can be replaced
  • the cylinder 42 of the first syringe 4 is supported by the syringe adapter 6 and a cylinder receiving part 110 provided in the first holding unit 11. Further, the cylinder 52 of the second syringe 5 is supported by the syringe adapter 6 and a cylinder receiving portion 120 provided on the support arm 14.
  • the cylinder receiving portions 110 and 120 protrude outward from the first holding unit 11 or the support arm 14.
  • the cylinder receivers 110 and 120 have a substantially U-shaped cross section along the outer shape of the cylinders 42 and 52 and can be exchanged together with the syringe adapter 6. That is, the cylinder receiving portions 110 and 120 can be exchanged according to the size or shape of the syringe.
  • the first holding unit 11 has a heater (not shown) that contacts the outer surface of the first syringe 4.
  • the heater is provided in a cylinder receiving part 110 provided in the first holding unit 11 and heats or keeps the cylinder 42 of the first syringe 4.
  • This heater is arranged on the upper surface of the cylinder receiving part 110 or is built in the cylinder receiving part 110. By heating with the heater, convection occurs in the contrast medium in the cylinder 42, and the stirring effect of the contrast medium can be further enhanced. This heating is performed at a temperature that does not cause the microbubbles to collapse. Further, by keeping the contrast medium warm by a heater, a predetermined temperature, for example, a temperature about the human body temperature can be maintained.
  • a conduit portion 43 is provided at the tip of the first syringe 4, and a conduit portion 53 is provided at the tip of the second syringe 5. And the holding member is not arrange
  • a tube 9 is connected to the conduit portions 43 and 53 when a chemical solution is injected.
  • the tube 9 includes a first tube 91 connected to the first syringe 4 and a second tube 92 connected to the second syringe 5.
  • the 1st tube 91 and the 2nd tube 92 are connected via the branch part.
  • the tube 9 has a distal end portion 95 connected to a catheter or the like, and a dripping cap is attached to the distal end portion 95.
  • a first connector 93 is attached to the end of the first tube 91, and a second connector 94 is attached to the conduit portion 43 of the first syringe 4.
  • the second connector 94 is inserted into the first connector 93 and is rotatably connected to the first connector 93.
  • the first holding unit 11 swings in a direction that intersects the axial direction of the first syringe 4.
  • the second connector 94 is rotatably connected to the first connector 93, the tube 9 is not twisted.
  • the second connector 94 and the first connector 93 can be screwed together. By screwing, even if the tube 9 moves according to the swing of the first syringe 4, the connection between the second connector 94 and the first connector 93 is not released.
  • a piston 44 is attached to the first syringe 4, and a piston 54 is attached to the second syringe 5.
  • the rear end of the piston 44 engages with the presser 160 of the first drive unit 16, and the rear end of the piston 54 engages with the presser 170 of the second drive unit 17.
  • the pressers 160 and 170 advance or retract the pistons 44 and 54 separately or simultaneously in the axial direction of the syringe.
  • the pistons 44 and 54 move forward and the contrast medium and physiological saline in the cylinders 42 and 52 are pushed out.
  • the extruded contrast agent and physiological saline are injected into the patient's blood vessel through the tube 9 and a catheter or the like connected to the distal end portion 95.
  • physiological saline is often injected after contrast agent injection, but the contrast agent and physiological saline can also be injected simultaneously.
  • the release valve 96 of the tube 9 When confirming the blood vessel, the release valve 96 of the tube 9 is used. When the release valve 96 is pushed, the liquid can flow from the blood vessel side to the second syringe 5 side. Therefore, it can be confirmed that the blood is returned by retracting the presser 170 to retract the piston 54. At this time, a valve is provided in the first connector 93 so that the contrast agent does not flow into the second syringe 5 from the first syringe 4. This valve is not opened below a predetermined pressure, and is opened when a predetermined pressure is exceeded. Therefore, the liquid can flow only in the direction from the first syringe 4 toward the distal end portion 95.
  • the release valve 96 is also provided with a valve that restricts the liquid to flow only in the direction from the second syringe 5 toward the distal end portion 95 when the chemical liquid is injected. After confirming that the blood has returned, a small amount of physiological saline is injected.
  • a three-way stopcock can be provided at the branch portion between the first tube 91 and the second tube 92. Thereby, the flow direction of a liquid can be switched manually or automatically.
  • the injector head 1 includes an operation unit 19 capable of operating the injection and stirring of the chemical solution, and a first drive unit 16 and a second drive unit for controlling the injection operation of the injector head 1. 17 and a control unit 18 for controlling the stirring unit 13.
  • the first drive unit 16 includes an injection motor 161 that drives the presser 160, and a conversion mechanism 162 that converts the rotational motion from the injection motor 161 into linear motion.
  • the second drive unit 17 includes an injection motor 171 that drives the presser 170 and a conversion mechanism 172 that converts the rotational motion from the injection motor 171 into a linear motion.
  • the stirring unit 13 includes a stirring motor 130 that drives the first holding unit 11 and a transmission mechanism 131 that transmits the rotational motion from the stirring motor to the first holding unit 11.
  • the first holding unit 11 is supported so as to be swingable in a direction intersecting the axial direction of the first syringe 4, preferably in a direction perpendicular to the first syringe 4, in a state sandwiched between the pair of support arms 14 and 15. That is, the shaft 141 is fixed to the distal end side of the first holding unit 11, and the first holding unit 11 is swingably supported by the support arm 14 via the shaft 141. A shaft 151 is fixed to the rear end side of the first holding unit 11, and the first holding unit 11 is swingably supported by the support arm 15 via the shaft 151.
  • the first holding unit 11 can swing in the axial direction with the central axis of the cylinder 42 of the first syringe 4 as the axis.
  • the shaft 151 passes through the shaft hole of the support arm 15, and the first holding unit 11 is connected to the transmission mechanism 131 of the stirring unit 13 through the shaft 151.
  • the shaft 141 is coaxial with the shaft 151, and the end of the shaft 141 passes through the shaft hole of the support arm 14. Thereby, the 1st holding
  • the stirring unit 13 is fixed to the support arm 14, and the second holding unit 12 is fixed and held while being sandwiched between the pair of support arms 14 and 15.
  • the operator When injecting a chemical solution, the operator operates the injector head 1 with the operation unit 19.
  • the operator inputs physical data of the patient such as weight, data on the type of the chemical solution, and the like from the operation unit 19.
  • the control unit 18 calculates an injection protocol such as an injection rate, an injection amount, and an injection time based on the input data.
  • the control part 18 of the injector head 1 operates the injector head 1 according to an injection
  • pouring protocol For example, when the operator inputs the start of injection, the control unit 18 drives the injection motors 161 and 171.
  • the rotational motions of the injection motors 161 and 171 are converted into linear motions by the conversion mechanisms 162 and 172 and transmitted to the pressers 160 and 170.
  • the injector head 1 includes an operation unit 19 and a control unit 18.
  • the operation unit 19 and the control unit 18 can be provided outside the injector head 1.
  • the injector head 1, the operation unit 19, and the control unit 18 are connected by wire or wireless, and the injector head 1 can be remotely operated.
  • the operator stirs the contrast agent before injecting the drug solution.
  • the operator attaches the first syringe 4 to the first holding unit 11.
  • the operator operates the operation unit 19 and inputs the start of the stirring operation.
  • the operation unit 19 transmits a control signal for starting the stirring operation to the control unit 18.
  • the control unit 18 that has received the control signal drives the stirring motor 130 to cause the stirring unit 13 to perform a predetermined stirring operation.
  • the rotational motion from the stirring motor 130 is transmitted to the shaft 151 via the transmission mechanism 131. Since the shaft 151 is fixed to the first holding unit 11, the first holding unit 11 swings according to the rotation of the shaft 151.
  • the stirring time is 10 seconds to 300 seconds
  • the rotation speed is 10 rpm to 120 rpm
  • the swing angle of the first holding unit 11 is 45 degrees to 360 degrees.
  • the stirring operation can be performed so as to repeat swinging in one direction and swinging in the opposite direction.
  • the first holding unit 11 is swung 180 degrees in one direction. That is, the first holding unit 11 is swung until the side where the first syringe 4 of the first holding unit 11 is attached faces downward. Thereafter, the first holding unit 11 is swung 180 degrees in the reverse direction. That is, the first holding unit 11 is swung so as to return to the original position.
  • the first holding unit 11 is swung 45 degrees in one direction. Thereafter, the first holding unit 11 is swung 90 degrees in the reverse direction. That is, the first holding unit 11 is swung 45 degrees in the reverse direction through the original position.
  • the stirring operation can be automatically started when the separation of the contrast agent is detected.
  • the separation of the contrast agent can be detected by a CCD camera or a sensor.
  • a CCD camera an image of the contrast agent in the cylinder 42 can be taken by the CCD camera, and the separation of the contrast agent can be recognized from the taken image.
  • it can be set so that the stirring operation is automatically performed every predetermined time.
  • control unit 18 performs control so as not to start injection during the stirring operation. That is, the control unit 18 starts injecting the chemical liquid after the first holding unit 11 stops swinging. Therefore, when the control unit 18 receives an injection start signal during the stirring operation, the control unit 18 drives the injection motors 161 and 171 after waiting for the stirring operation to end. Thereby, the tube 9 does not move due to the swinging of the first holding unit 11, and it is possible to prevent the catheter or the like from being detached from the patient during the injection.
  • the control part 18 can also make the stirring unit 13 perform stirring operation, when starting injection
  • control unit 18 that has received the injection start control signal causes the stirring unit 13 to perform the stirring operation, and drives the injection motors 161 and 171 after the stirring operation is completed.
  • the control unit 18 performs control so that the injection is not started during the stirring operation.
  • the stirring operation can be performed during the injection.
  • the first drive unit 16 and the second drive unit 17 will be described with reference to FIG.
  • the first drive unit 16 is arranged in the cover of the first holding unit 11, and the second drive unit 17 is arranged in the cover of the second holding unit 12.
  • the first drive unit 16 and the second drive unit 17 have injection motors 161 and 171 and conversion mechanisms 162 and 172, respectively.
  • the injection motors 161 and 171 are, for example, stepping motors.
  • the conversion mechanisms 162 and 172 include ball screws 163 and 173 and ball nut units 160 and 170 that function as a presser.
  • the first holding unit 11 includes a frame including a front end member 114 located on the front end side, a rear end member 115 located on the rear end side, and a beam member 116 that connects the front end member 114 and the rear end member 115.
  • a frame including a front end member 114 located on the front end side, a rear end member 115 located on the rear end side, and a beam member 116 that connects the front end member 114 and the rear end member 115.
  • the ball screws 163 and 173 are connected to the output shafts of the injection motors 161 and 171 via two pulleys and a belt (not shown).
  • One pulley is fixed to the output shafts of the injection motors 161 and 171, and the other pulley is fixed to the ends of the ball screws 163 and 173.
  • Belts are wound around the two pulleys, and the rotational movements of the injection motors 161 and 171 are transmitted to the ball screws 163 and 173. Instead of the two pulleys and the belt, the rotational motion may be transmitted to the ball screws 163 and 173 by a gear.
  • the ball screw 163 of the first driving unit 16 is supported by the front end member 114 and the rear end member 115 of the frame so as to be rotatable and immovable in the axial direction.
  • a guide shaft 165 passing through the ball nut unit 160 is fixed to the front end member 114 and the rear end member 115.
  • the ball screw 173 of the second drive unit 17 is supported by the support arms 14 and 15 so as to be rotatable and immovable in the axial direction.
  • a guide shaft 175 that passes through the ball nut unit 170 is fixed to the support arms 14 and 15. The ball nut units 160 and 170 are screwed into the ball screws 163 and 173.
  • the ball nut units 160 and 170 linearly move along the guide shafts 165 and 175 as the ball screws 163 and 173 rotate. Specifically, when the injection motors 161 and 171 are driven, the rotational motion is transmitted to the ball screws 163 and 173 via the pulleys and the belt, and the ball screws 163 and 173 rotate. When the ball screws 163 and 173 rotate, the ball nut units 160 and 170 move forward or backward along the ball screws 163 and 173 according to the rotation direction. Further, the rear ends of the pistons 44 and 54 are engaged with and held by the ball nut units 160 and 170 via the engaging portions 164 and 174.
  • the stirring unit 13 includes a stirring motor 130 and a transmission mechanism 131 that transmits the rotational force from the stirring motor 130 to the shaft 151.
  • the stirring motor 130 is, for example, a stepping motor.
  • the first holding unit 11 is connected to the transmission mechanism 131 via the shaft 151.
  • the transmission mechanism 131 includes a first gear 132, a second gear 133, a third gear 134, a fourth gear 135, and a belt 136.
  • the first gear 132 is connected to and fixed to the output shaft of the stirring motor 130, and the second gear 133 has external teeth that mesh with the external teeth of the first gear 132.
  • the third gear 134 is coaxial with the second gear 133 and is bolted and fixed to the second gear 133.
  • the third gear 134 and the fourth gear 135 have external teeth that mesh with the internal teeth of the belt 136.
  • the fourth gear 135 is fixed to the shaft 151, and the shaft 151 is fixed to the rear end member 115 of the first holding unit 11.
  • Rotational motion from the stirring motor 130 is transmitted to the first gear 132 via the output shaft.
  • the second gear 133 rotates according to the rotation of the first gear 132.
  • the third gear 134 fixed to the second gear 133 rotates around the shaft 152 as the second gear 133 rotates.
  • the belt 136 having the internal teeth that mesh with the external teeth of the third gear 134 rotates according to the rotation of the third gear 134.
  • the fourth gear 135 having external teeth that mesh with the internal teeth of the belt 136 rotates according to the rotation of the belt 136. Since the shaft 151 is fixed to the fourth gear 135, the shaft 151 rotates according to the rotation of the fourth gear 135.
  • the shaft 151 is fixed to the rear end member 115 of the first holding unit 11. Therefore, according to the rotation of the shaft 151, the first holding unit 11 swings around the shaft 151 with respect to the support arms 14 and 15.
  • the stirring motor 130 is controlled by the control unit 18 so as to swing the first holding unit 11 at a predetermined swing angle. That is, the stirring motor 130 is controlled so that the first holding unit 11 reciprocates within a predetermined angle range from a horizontal direction with respect to the central axis of the shaft 151. Therefore, the first syringe 4 held and fixed by the first holding unit 11 also swings together with the first holding unit 11. Thereby, the contrast agent in the 1st syringe 4 is stirred.
  • the injector head 1 is used in a two-cylinder injector including a first holding unit 11 and a second holding unit 12. Therefore, the contrast agent can be agitated by swinging the first syringe 4 held by the first holding unit 11 as the other holding unit with the second holding unit 12 as one holding unit as a base. it can.
  • the agitated contrast agent can be injected while being swept together with physiological saline.
  • the injector head 1 can be suitably used.
  • the contrast agent does not stay between the injection site and the heart, and there is no possibility of adversely affecting the quality of the captured image.
  • As an injection method it is possible to inject contrast medium and physiological saline again after injecting physiological saline followed by injection of contrast medium. As a result, the inspection can be performed twice.
  • the chemical solution in the syringe is agitated by swinging the holding unit that fixes and holds the syringe by the agitation unit. That is, the syringe swings together with the holding unit while being fixed to the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean.
  • the first holding unit 11 is swung in a direction intersecting with the axial direction of the first syringe 4.
  • the first holding unit 11 swings in a direction along the axial direction of the first syringe 4.
  • the same reference numerals will be given to the components described in the first embodiment, and description thereof will be omitted. Except where specifically described, the constituent elements having the same reference numerals perform substantially the same operations and functions, and the effects thereof are also substantially the same.
  • beams 216 and 217 are provided between the support arms 14 and 15.
  • the first holding unit 11 is supported so as to be swingable with respect to the beams 216 and 217 via shafts 241 and 251.
  • the shaft 241 on the stirring unit 13 side passes through the shaft hole of the beam 217 and is connected and fixed to the transmission mechanism 131.
  • the shaft 251 on the second holding unit 12 side passes through the shaft hole formed in the beam 216.
  • the second holding unit 12 and the stirring unit 13 are arranged between the support arms 14 and 15 and are fixed to the support arms 14 and 15.
  • the stirring unit 13 includes a stirring motor 130 and a transmission mechanism 131.
  • the rotational motion from the stirring motor 130 is transmitted to the first gear 132 of the transmission mechanism 131 via the output shaft.
  • the fourth gear 135 rotates via the second gear 133, the third gear 134, and the belt 136.
  • the shaft 241 is fixed to the fourth gear 135, the shaft 241 rotates according to the rotation of the fourth gear 135.
  • the shaft 241 is fixed to the beam member 116 of the first holding unit 11 described above, the first holding unit 11 swings as the shaft 241 rotates.
  • maintenance unit 11 is stirred.
  • the chemical solution in the syringe is stirred by swinging the holding unit that fixes and holds the syringe by the stirring unit. That is, the syringe swings together with the holding unit while being fixed to the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean.
  • the stirring unit 13 includes a stirring motor 130 and a link mechanism 331 connected to the stirring motor 130.
  • the first holding unit 11 is connected to the link mechanism 331.
  • the link mechanism 331 includes a disk 332 fixed to the output shaft of the stirring motor 130 and a rod 333 connected to the disk 332 via a pin at a position shifted from the rotation axis of the disk 332.
  • the frame of the first holding unit 11 includes a front end member 314 and a rear end member 315, and a beam member 316 positioned between the front end member 314 and the rear end member 315.
  • the beam member 316 is fixed to the front end member 314 and the rear end member 315 by bolts.
  • the end of the rod 333 is connected to a slider 334 protruding from the beam member 316 via a pin.
  • the tip member 314 is connected to the cover 318 via two slide shafts 317.
  • the front end member 314, the rear end member 315, and the beam member 316 can slide linearly in the axial direction of the first syringe 4 within the cover 318. That is, the tip member 314 is connected to the slider shaft 317 so as to be able to advance and retract.
  • the control unit 18 drives the stirring motor 130.
  • the disk 332 connected to the output shaft rotates.
  • the rod 333 connected to the disk 332 is interlocked with the rotation of the disk 332.
  • the slider 334 reciprocates linearly in the axial direction of the first syringe 4 according to the movement of the rod 333.
  • the first holding unit 11 performs a linear reciprocating motion in the axial direction of the first syringe 4.
  • the first syringe 4 is fixed and held in the first holding unit 11. Therefore, the first syringe 4 performs a linear reciprocating motion as indicated by an arrow A in FIG. 7 as the first holding unit 11 slides. Thereby, the contrast agent in the 1st syringe 4 can be stirred.
  • the drug solution in the syringe is stirred by sliding the holding unit that holds and holds the syringe with the stirring unit. That is, the syringe slides together with the holding unit while being fixed to the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean.
  • the injector 1 for injecting the chemical solution of the fourth embodiment also has a first drive unit 16 that pushes out the contrast medium as the chemical solution from the first syringe 4 filled with the chemical solution, and a first holding that fixes and holds the first syringe 4.
  • a unit 11 and a support arm 14 that supports the first holding unit 11 are provided.
  • the injector 1 is provided with the stirring unit 13 which moves the 1st syringe 4 in order to stir the chemical
  • the stirring unit 13 has a vibration motor as a stirring motor in the vibration box 430.
  • the vibration motor is driven by the control unit 18, and vibration is transmitted to the first syringe 4.
  • the vibration box 430 is supported by a swing arm 431 that can swing around an axis.
  • the swing arm 431 is connected to the tip member 314 of the first holding unit 11 or the support arm 14 (not shown) via a shaft. Therefore, the swing arm 431 and the vibration box 430 can swing between the contact position and the retracted position.
  • the swing arm 431 is fixed by a lock means (not shown) at the contact position shown in FIG.
  • the vibration box 430 contacts the upper surface of the first syringe 4 at the contact position.
  • the vibration box 430 is separated from the first syringe 4 in the retracted touch position.
  • the first arm 4 is swung after the rocking arm 431 is unlocked and moved in the direction indicated by the arrow B in FIG. 8.
  • the vibration box 430 can be brought into contact with the lower surface or the side surface of the first syringe 4.
  • the swing arm 431 is configured to be swingable between a contact position below the first syringe 4 and a retracted position.
  • the chemical solution in the syringe is stirred by the stirring unit applying vibration to the syringe fixed and held by the holding unit. That is, the syringe vibrates while being fixed to and held by the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean.
  • an injector according to a fifth embodiment will be described with reference to FIG.
  • the support arm 14 is provided on the front end side of the first holding unit 11, and the support arm 15 is provided on the rear end side of the first holding unit 11.
  • the support member that supports the first holding unit 11 is disposed so as to avoid the distal end side of the first holding unit 11.
  • differences from the first embodiment will be described, and the same reference numerals will be given to the components described in the first embodiment, and description thereof will be omitted. Except where specifically described, the constituent elements having the same reference numerals perform substantially the same operations and functions, and the effects thereof are also substantially the same.
  • the injector head 1 is provided with a first holding unit 11, a second holding unit 12, and a stirring unit 13.
  • a support arm 15 (not shown) as a support member is disposed in the stirring unit 13.
  • the support arm 14 is not provided, and the distal end side of the first holding unit 11 is a free end. Therefore, there is no possibility that the first syringe 4 contacts the support arm 14 during the stirring operation. Thereby, the freedom degree of stirring operation can be raised.
  • the stirring operation of the fifth embodiment can be performed so as to rotate the first holding unit 11 in one direction for a predetermined time.
  • stirring operation can also be performed as follows. First, the first holding unit 11 is swung 180 degrees in one direction. That is, the first holding unit 11 is swung until the side where the first syringe 4 of the first holding unit 11 is attached faces downward. Thereafter, the first holding unit 11 is swung 360 degrees in the reverse direction. That is, the first holding unit 11 is swung in the reverse direction until it passes through the original position and the side on which the first syringe 4 is mounted faces downward.
  • the stirring operation can be performed in the same manner as in the first embodiment.
  • the stirring unit 13 includes a stirring motor 130 and a transmission mechanism 131.
  • the rotational motion from the stirring motor 130 is transmitted to the first gear 132 of the transmission mechanism 131 via the output shaft.
  • the fourth gear 135 rotates via the second gear 133, the third gear 134, and the belt 136.
  • the shaft 151 is fixed to the fourth gear 135, the shaft 151 rotates according to the rotation of the fourth gear 135.
  • the shaft 151 is fixed to the rear end member 115 of the first holding unit 11, the first holding unit 11 swings as the shaft 151 rotates.
  • maintenance unit 11 is stirred.
  • the first holding unit 11 and the stirring unit 13 are separated by a predetermined distance. Thereby, it is possible to prevent the operator's finger from being accidentally pinched or caught in the swing while the first holding unit 11 is swinging.
  • the first holding unit 11 can be covered with a transparent cover.
  • the cover has an open front end so as not to limit the swing of the first holding unit 11.
  • the inner space of the cover is configured so as not to come into contact with the swinging first holding unit 11. Thereby, since the upper surface side, side surface side, and lower surface side of the 1st holding
  • the operation unit 519 of the fifth embodiment is a touch panel supported by a pole extending above the stirring unit 13.
  • the touch panel 519 displays the injection status. Further, the operator can operate the injector head 1 by operating the touch panel 519.
  • the chemical solution in the syringe is stirred by swinging the holding unit that fixes and holds the syringe by the stirring unit. That is, the syringe swings together with the holding unit while being fixed to the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean. In addition, the arrangement
  • the injector head 1 is provided with a first holding unit 11, a second holding unit 12, and a stirring unit 13.
  • a support arm 14 (not shown) as a support member is disposed in the stirring unit 13.
  • the first holding unit 11 is supported by the support arm 14 and the support arm 15.
  • the cover that accommodates the stirring unit 13 and the second holding unit 12 is integrally formed.
  • the stirring unit 13 is disposed on the distal end side of the first holding unit 11. That is, the distal end side of the first holding unit 11 is connected to the transmission mechanism 131 of the stirring unit 13 via a shaft 141 (not shown).
  • the control part 18 accommodated in the cover is connected to the 1st holding
  • the length of the first holding unit 11 is longer than that of the first syringe 4 so that the first syringe 4 does not protrude from the first holding unit 11. Therefore, there is no possibility that the first syringe 4 contacts the support arm 14 or the stirring unit 13. Thereby, the freedom degree of stirring operation can be raised. Therefore, the stirring operation of the sixth embodiment can be performed so as to rotate the first holding unit 11 in one direction for a predetermined time. Moreover, stirring operation can also be performed as follows. First, the first holding unit 11 is swung 180 degrees in one direction. That is, the first holding unit 11 is swung to a position where the side on which the first syringe 4 of the first holding unit 11 is attached faces downward.
  • the first holding unit 11 is swung 360 degrees in the reverse direction. That is, the first holding unit 11 is swung in the reverse direction until it passes through the original position and the side on which the first syringe 4 is mounted faces downward.
  • the stirring operation can be performed in the same manner as in the first embodiment.
  • the stirring unit 13 of the sixth embodiment also includes a stirring motor 130 and a transmission mechanism 131.
  • the rotational motion from the stirring motor 130 is transmitted to the first gear 132 of the transmission mechanism 131 via the output shaft.
  • the fourth gear 135 rotates via the second gear 133, the third gear 134, and the belt 136.
  • the shaft 141 is fixed to the fourth gear 135, the shaft 141 rotates according to the rotation of the fourth gear 135. Since the shaft 141 is fixed to the tip member 114 of the first holding unit 11, the first holding unit 11 swings as the shaft 141 rotates.
  • the output shaft of the stirring motor 130 can be directly connected to the shaft 141.
  • the operator tilts the first syringe 4 and the second syringe 5 at a predetermined angle before performing the stirring operation. That is, the first holding unit 11 and the second holding unit 12 are manually tilted to the injection position. And the 1st holding
  • maintenance unit 11 is stirred.
  • a lifter can also be provided in order to incline the 1st holding
  • the operator operates the operation unit 19 and lifts the first holding unit 11 and the second holding unit 12 with a lifter.
  • maintenance unit 12 can be inclined automatically.
  • the chemical solution in the syringe is stirred by swinging the holding unit that fixes and holds the syringe by the stirring unit. That is, the syringe swings together with the holding unit while being fixed to the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean.
  • the chemical solution injection system includes an injector 100 as an injection device for injecting a chemical solution, and an external storage unit 700 such as a database server or an in-hospital information system that communicates with the injector 100 and stores patient information (medical chart information) and the like.
  • the chemical liquid injection system can also include a medical imaging apparatus 800 such as an ultrasonic diagnostic apparatus.
  • the injector head 1 of the injector 100 is provided with a control unit 18, an operation unit 19, a communication unit 71, and an RFID reader 72.
  • the first syringe 4 is provided with an RFID chip 73.
  • the RFID chip 73 stores at least chemical liquid data related to the chemical liquid to be injected.
  • the data includes, for example, data such as the name or ID of the chemical solution, viscosity, expiration date, syringe capacity, lot number, and the like.
  • the RFID chip 73 can also store data later by the injector head 1 or the like.
  • the RFID reader 72 is provided at a position where it can wirelessly communicate with the RFID chip 73 only when the first syringe 4 is correctly attached to the first holding unit 11.
  • the control unit 18 receives the injection condition data.
  • the control unit 18 acquires chemical liquid data from the RFID chip 73 by the RFID reader 72.
  • the control part 18 calculates an injection
  • the control unit 18 can also acquire injection condition data or an injection protocol from the external storage unit 700 via the communication unit 71.
  • the control unit 18 controls the first driving unit 16 and the second driving unit 17 according to the injection protocol to perform the injection operation. Furthermore, the control part 18 controls the stirring unit 13 as mentioned above, and performs stirring operation.
  • control unit 18 generates history data that records the history of the injection operation and the stirring operation. And the control part 18 can transmit historical data to the external memory
  • the history data of the stirring operation may include data such as the name of the chemical solution, the stirring time, and the rocking speed.
  • the history data of the injection operation may include data such as the name of the chemical solution, the injection time, and the injection speed.
  • the control unit 18 can also acquire data relating to an image, for example, data such as an ID, an imaging time, or an imaging region, from the ultrasonic diagnostic apparatus via the communication unit. And the control part 18 can memorize
  • the operator can send and receive information such as an injection protocol to the injector 100 using a terminal of the in-hospital information system.
  • the injector 100 includes a communication unit 71 that communicates with an external device. Thereby, the injector 100 can transmit / receive information to / from the medical imaging apparatus 800 such as an ultrasonic diagnostic apparatus or the external storage unit 700 such as a database server.
  • the medical imaging apparatus 800 such as an ultrasonic diagnostic apparatus or the external storage unit 700 such as a database server.
  • the injector 100 can transmit history data in which the history of the injection operation and the agitation operation is recorded to the external storage unit 700, or can receive a chemical injection protocol or the like from the external storage unit 700.
  • information such as the weight of the patient can be received from the external storage means 700 and the injection protocol can be calculated by the control unit 18 of the injector 100.
  • appropriate imaging can be performed by linking the injector 100 and the external storage unit 700 that stores patient information. Further, by linking the medical imaging apparatus 800, it is possible to perform imaging at an appropriate timing after the injection of the contrast medium.
  • the transmission mechanism 131 of the stirring unit 13 may be omitted, and the output shaft of the stirring motor 130 may be connected to the shaft 151.
  • the drive unit may have an ultrasonic motor instead of the stepping motor.
  • the second holding unit 12 is fixed, it can be swung in the same manner as the first holding unit 11.
  • the first holding unit 11 and the stirring unit 13 or the support arm 15 can be separated.
  • maintenance unit 11 and the support arm 14 can also be spaced apart. Thereby, it is possible to prevent the operator's finger from being accidentally pinched or involved in swinging.
  • the first holding unit 11 can be covered with a transparent cover.
  • the second holding unit 12 may further be provided with a heater (not shown) that contacts the outer surface of the second syringe 5.
  • the heater is provided in a cylinder receiving portion 120 provided in the second holding unit 12 and heats or keeps the cylinder 52 of the second syringe 5.
  • This heater is arranged on the upper surface of the cylinder receiving part 120 or is built in the cylinder receiving part 120.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Provided is an agitating injection device that injects a drug solution and agitates said drug solution inside a loaded syringe. Said agitating injection device is provided with the following: a first drive unit that propels a first drug solution out of a first syringe filled with said first drug solution; a first holding unit that immobilizes and holds the first syringe; a support member that supports the first holding unit; and an agitation unit that is connected to the first holding unit and moves same in order to agitate the first drug solution inside the first syringe.

Description

撹拌用注入装置Stirring injection device
 本発明は、薬液を注入する注入装置であって、装着されたシリンジ内の薬液を撹拌する撹拌用注入装置に関する。 The present invention relates to an injection device for injecting a chemical solution, and relates to an injection device for stirring for stirring the chemical solution in a mounted syringe.
 医療用撮影装置、例えば超音波診断装置による撮影の際に使用される薬液として、懸濁液からなる造影剤がある。この造影剤は、超音波を散乱させるためにマイクロバブル、固体粒子等を含む。そして、超音波診断をする際には、この造影剤が充填されたシリンジが注入装置に装着され、造影剤を患者の体内に注入した後に撮影が行われる。超音波診断装置は、マイクロバブル又は固体粒子に入射して反射された超音波を分析することにより、体内の画像を撮影する。しかし、シリンジを注入装置に装着した後の経過時間によっては、造影剤に分離が生じてしまい、造影剤の内容物の濃度に偏りが生じてしまうことがある。 There is a contrast medium made of a suspension as a chemical solution used for imaging by a medical imaging apparatus, for example, an ultrasonic diagnostic apparatus. This contrast agent contains microbubbles, solid particles and the like in order to scatter ultrasonic waves. When performing an ultrasonic diagnosis, a syringe filled with the contrast agent is attached to an injection device, and imaging is performed after the contrast agent is injected into the patient's body. The ultrasonic diagnostic apparatus captures an image of the inside of a body by analyzing ultrasonic waves that are incident on and reflected by microbubbles or solid particles. However, depending on the elapsed time after the syringe is mounted on the injection device, the contrast agent may be separated, and the concentration of the contrast agent content may be biased.
 そこで、特許文献1には、注入装置のシリンジ内の懸濁液を十分に撹拌された状態に維持するための注射システムが開示されている。この注射システムは、水性の液体キャリア中の微粒子の懸濁液を注射することによって患者を治療するための注射システムである。そして、注射システムは、バレルに懸濁液を充填可能なシリンジと、患者へ懸濁液を注射するために制御可能に動く自動電気駆動手段とから構成されている。また、注射システムは、システム内のシリンジを保持し且つ懸濁液内の微粒子を撹拌する撹拌手段を有している。この撹拌手段は、シリンジに与えられた運動により、重力もしくは浮力による微粒子の分離を防止することによって、懸濁液の均一性を維持している。 Therefore, Patent Document 1 discloses an injection system for maintaining the suspension in the syringe of the injection device in a sufficiently stirred state. The injection system is an injection system for treating a patient by injecting a suspension of microparticles in an aqueous liquid carrier. The injection system consists of a syringe capable of filling the barrel with suspension and automatic electric drive means that controllably move to inject the suspension into the patient. The injection system also has a stirring means for holding the syringe in the system and stirring the fine particles in the suspension. This stirring means maintains the uniformity of the suspension by preventing the separation of the fine particles due to gravity or buoyancy by the movement given to the syringe.
 より具体的に特許文献1には、撹拌手段として、シリンジバレルに連続した回転を与えるために、当該シリンジバレルに接触したローラーが開示されている。このローラーは、当該ローラー上に配置されたシリンジを保持すると共に、保持したシリンジを回転させる。これにより、ローラーは、シリンジのバレル内の懸濁液を攪拌することができる。また、特許文献1には、撹拌手段として、回転可能な形でシリンジを支持する2つのブラケットが開示されている。そして、これらのブラケットは、シリンジを保持し且つシリンジを回転させる。これにより、ブラケットは、シリンジのバレル内の懸濁液を攪拌する。 More specifically, Patent Document 1 discloses a roller that is in contact with a syringe barrel in order to give continuous rotation to the syringe barrel as a stirring means. The roller holds the syringe disposed on the roller and rotates the held syringe. Thereby, the roller can stir the suspension in the barrel of the syringe. Patent Document 1 discloses two brackets that support a syringe in a rotatable manner as stirring means. These brackets hold the syringe and rotate the syringe. Thereby, the bracket stirs the suspension in the barrel of the syringe.
特許第3665566号公報Japanese Patent No. 3665566
 しかし、特許文献1に開示された注射システムにおいては、以下のような問題が生じてしまう。すなわち、ローラー上に載置することによってシリンジを保持する場合は、シリンジがずれ易く注入装置から外れてしまう恐れがある。また、注入する際には、患者にエアを注入してしまうことを防止するために、注入装置のシリンジが装着される側(シリンジの先端側)を床面に向けた状態でシリンジを装着することがある。この場合、ローラー上に載置されたシリンジは、重力によってずれて注入装置から外れてしまう。 However, the injection system disclosed in Patent Document 1 has the following problems. That is, when a syringe is held by being placed on a roller, the syringe is likely to be displaced and may be detached from the injection device. In addition, when injecting, in order to prevent injecting air into the patient, the syringe is mounted with the syringe mounting side (the syringe tip side) facing the floor surface. Sometimes. In this case, the syringe placed on the roller shifts due to gravity and comes off the injection device.
 また、シリンジをブランケットにより保持する場合も、保持されたシリンジはずれ易い。すなわち、シリンジを回転可能に保持するために、保持手段でもあるブランケットにシリンジを固定することができない。さらに、薬液を外部から観察する必要があるので、シリンジを固定するためにシリンジの上面を覆う部材を設けることは困難である。そのため、ブランケットにより保持する場合も、衝撃が加わった場合にはシリンジがずれてしまい、注入装置から外れてしまう又は注入装置内でシリンジの姿勢が傾いてしまう恐れがある。 Also, when the syringe is held by a blanket, the held syringe is easily detached. That is, since the syringe is rotatably held, the syringe cannot be fixed to the blanket that is also a holding means. Furthermore, since it is necessary to observe the chemical solution from the outside, it is difficult to provide a member that covers the upper surface of the syringe in order to fix the syringe. Therefore, also when hold | maintaining with a blanket, when an impact is added, a syringe will slip | deviate and it may remove | deviate from an injection apparatus or there exists a possibility that the attitude | position of a syringe may incline within an injection apparatus.
 さらに、いずれの場合であっても、シリンジの先端側を床面に向けた状態でシリンジを回転させると、シリンジの姿勢が注入装置内で傾いてしまう恐れがある。そして、シリンジの姿勢が傾いてしまうと、ピストンを押す力はピストンに対して不均一に加わる。そのため、ピストン又はシリンダの破損が生じる可能性、若しくは正確な注入が困難になる可能性がある。また、シリンジが注入装置から外れてしまうと、造影剤の注入が停止してしまう。 Furthermore, in any case, if the syringe is rotated in a state where the tip side of the syringe faces the floor, the posture of the syringe may be tilted in the injection device. And if the attitude | position of a syringe will incline, the force which pushes a piston will be added unevenly with respect to a piston. Therefore, damage to the piston or cylinder may occur, or accurate injection may be difficult. Further, when the syringe is detached from the injection device, the injection of the contrast agent is stopped.
 また、シリンジは、撹拌手段によって保持されている。そのため、保持可能なシリンジのサイズ又は形状は、撹拌手段が対応し得るサイズ又は形状に制限されてしまう。そして、サイズ又は形状が異なるシリンジを装着するためには、撹拌手段を交換しなければならない。しかし、シリンジに応じて撹拌手段を購入し交換するとなると、ユーザーに対するコストの負担が大きくなってしまう。さらに、シリンジの先端部分は、清潔な状態に維持される必要がある。しかし、ブランケットが先端部分を保持する形態においては、先端部分が汚れてしまう可能性がある。 Also, the syringe is held by stirring means. Therefore, the size or shape of the syringe that can be held is limited to the size or shape that the stirring means can accommodate. And in order to mount | wear with the syringe from which a size or a shape differs, you have to exchange a stirring means. However, if the stirring means is purchased and replaced according to the syringe, the cost burden on the user increases. Furthermore, the tip portion of the syringe needs to be kept clean. However, in the form in which the blanket holds the tip portion, the tip portion may become dirty.
 上記課題を解決するため、本発明の撹拌用注入装置は、薬液を注入する注入装置であって、第1薬液が充填された第1シリンジから前記第1薬液を押し出す第1駆動部と、前記第1シリンジを固定し且つ保持する第1保持ユニットと、前記第1保持ユニットを支持する支持部材と、前記第1保持ユニットに接続されると共に、前記第1シリンジ内の前記第1薬液を撹拌するために、前記第1保持ユニットを動かす撹拌ユニットとを備える。 In order to solve the above-mentioned problem, an injection device for agitation according to the present invention is an injection device for injecting a chemical solution, the first drive unit for extruding the first chemical solution from a first syringe filled with the first chemical solution, A first holding unit that fixes and holds the first syringe, a support member that supports the first holding unit, and the first drug solution in the first syringe are agitated while being connected to the first holding unit. And a stirring unit for moving the first holding unit.
 また、本発明の撹拌用注入装置は、薬液を注入する注入装置であって、薬液が充填されたシリンジから前記薬液を押し出す駆動部と、前記シリンジを固定し且つ保持する保持ユニットと、前記保持ユニットを支持する支持部材と、前記保持ユニットから離間した位置において前記シリンジの外面に接触すると共に、前記シリンジ内の前記薬液を撹拌するために、前記シリンジを動かす撹拌ユニットとを備える。 The stirring injection device of the present invention is an injection device for injecting a chemical solution, a drive unit for pushing out the chemical solution from a syringe filled with the chemical solution, a holding unit for fixing and holding the syringe, and the holding device A support member that supports the unit, and a stirring unit that contacts the outer surface of the syringe at a position spaced from the holding unit and moves the syringe in order to stir the drug solution in the syringe.
 本発明の撹拌用注入装置によれば、シリンジが保持ユニットに固定され且つ保持されている。そのため、シリンジの先端側を床面に向けた状態でも、撹拌動作の最中にシリンジがずれてしまうことを抑制できる。また、シリンジの先端部分を清潔な状態に維持したまま、薬液を撹拌することができる。さらに、さまざまなサイズ又は形状のシリンジを、撹拌用注入装置に装着することができる。 According to the stirring injection device of the present invention, the syringe is fixed to and held by the holding unit. Therefore, even if the tip end side of the syringe is directed to the floor surface, it is possible to prevent the syringe from shifting during the stirring operation. In addition, the chemical solution can be agitated while maintaining the tip portion of the syringe in a clean state. In addition, syringes of various sizes or shapes can be attached to the stirring injection device.
 本発明のさらなる特徴は、添付図面を参照して例示的に示した以下の実施例の説明から明らかになる。 Further features of the present invention will become apparent from the following description of embodiments, given by way of example with reference to the accompanying drawings.
スタンドに保持された第1実施形態の注入装置を示す概略斜視図である。It is a schematic perspective view which shows the injection apparatus of 1st Embodiment hold | maintained at the stand. 第1実施形態の注入装置のヘッド部分を示す概略斜視図である。It is a schematic perspective view which shows the head part of the injection apparatus of 1st Embodiment. 第1実施形態の注入装置を示す概略ブロック図である。It is a schematic block diagram which shows the injection apparatus of 1st Embodiment. 保持ユニット及び撹拌ユニットの内部構造を示す概略分解図である。It is a schematic exploded view which shows the internal structure of a holding | maintenance unit and a stirring unit. 撹拌ユニットの内部構造を示す概略図である。It is the schematic which shows the internal structure of a stirring unit. 第2実施形態の注入装置を示す概略ブロック図である。It is a schematic block diagram which shows the injection apparatus of 2nd Embodiment. 第3実施形態の注入装置を示す概略図である。It is the schematic which shows the injection apparatus of 3rd Embodiment. 第4実施形態の注入装置を示す概略図である。It is the schematic which shows the injection apparatus of 4th Embodiment. 第5実施形態の注入装置を示す概略図である。It is the schematic which shows the injection apparatus of 5th Embodiment. 第6実施形態の注入装置を示す概略図である。It is the schematic which shows the injection apparatus of 6th Embodiment. 第6実施形態における一方向への揺動の様子を示す概略図である。It is the schematic which shows the mode of the rocking | fluctuation to one direction in 6th Embodiment. 第6実施形態における逆方向への揺動の様子を示す概略図である。It is the schematic which shows the mode of the rocking | fluctuation to the reverse direction in 6th Embodiment. 第7実施形態における逆方向への揺動の様子を示す概略図である。It is the schematic which shows the mode of the rocking | fluctuation in the reverse direction in 7th Embodiment.
 以下、本発明を実施するための例示的な実施例を、図面を参照して詳細に説明する。ただし、以下の実施例で説明する寸法、材料、形状、構成要素の相対的な位置等は任意であり、本発明が適用される装置の構成又は様々な条件に応じて変更できる。また、特別な記載がない限り、本発明の範囲は、以下に説明される実施例で具体的に記載された形態に限定されるものではない。 Hereinafter, exemplary embodiments for carrying out the present invention will be described in detail with reference to the drawings. However, dimensions, materials, shapes, relative positions of components, and the like described in the following embodiments are arbitrary and can be changed according to the configuration of the apparatus to which the present invention is applied or various conditions. Unless otherwise specified, the scope of the present invention is not limited to the embodiments specifically described in the examples described below.
[第1実施形態]
 図1は、医療用撮影装置、例えば超音波診断装置によって患者の体内を撮影する際に使用される注入装置(インジェクター)100と、注入装置のヘッド部分であるインジェクターヘッド1を保持するスタンド2とを示す。スタンド2は、床面に置かれた可動式のスタンドベースと、スタンドベース上のスタンドポールとを有する。そして、インジェクターヘッド1は、スタンドポールの上部又は脇に保持されている。また、インジェクターヘッド1は、スタンドポールに左右方向又は上下方向に回動自在に保持されている。これにより、インジェクターヘッド1は、当該インジェクターヘッド1の先端側(シリンジが装着される側)を床面に向ける姿勢と、当該インジェクターヘッド1の後端側(シリンジが装着されない側)を床面に向ける姿勢とに回動させることができる。なお、図1においては、シリンジがインジェクターヘッド1に装着され、薬液を注入する準備が整った状態を示している。そのため、インジェクターヘッド1は、当該インジェクターヘッド1の先端側が床面に向くように傾いている。
[First Embodiment]
FIG. 1 shows an injection device (injector) 100 used when a patient's body is imaged by a medical imaging device, for example, an ultrasonic diagnostic device, and a stand 2 that holds an injector head 1 that is a head portion of the injection device. Indicates. The stand 2 has a movable stand base placed on the floor and a stand pole on the stand base. The injector head 1 is held on the top or side of the stand pole. The injector head 1 is held by a stand pole so as to be rotatable in the left-right direction or the up-down direction. Thereby, the injector head 1 has a posture in which the tip side (side where the syringe is mounted) of the injector head 1 is directed to the floor surface, and the rear end side (side where the syringe is not mounted) of the injector head 1 is the floor surface. It can be rotated to the direction it faces. FIG. 1 shows a state in which a syringe is attached to the injector head 1 and preparations for injecting a chemical solution are ready. Therefore, the injector head 1 is inclined so that the tip side of the injector head 1 faces the floor surface.
 薬液を注入するインジェクター100は、第1薬液としての造影剤と、第2薬液としての生理食塩水とを患者に注入する。そのため、図2に示すように、インジェクターヘッド1は、造影剤が充填された第1シリンジ4を固定し且つ保持する第1保持ユニット11と、生理食塩水が充填された第2シリンジ5を固定し且つ保持する第2保持ユニット12と、第1保持ユニット11及び第2保持ユニット12を支持する支持部材としての支持アーム14とを備える。第1保持ユニット11及び第2保持ユニット12の内部機構は、第1保持ユニット11及び第2保持ユニット12のカバー内に収容されている。また、インジェクターヘッド1は、第1保持ユニット11に接続される撹拌ユニット13を備える。撹拌ユニット13の内部機構は、撹拌ユニット13のカバー内に収容されている。そして、撹拌ユニット13は、第1シリンジ4内の造影剤を撹拌するために、第1保持ユニット11を動かす。なお、第1シリンジ4から造影剤を押し出す第1駆動部16は、第1保持ユニット11内に設けられている。そして、第2シリンジ5から生理食塩水を押し出す第2駆動部17は、第2保持ユニット12内に設けられている。 The injector 100 that injects the chemical solution injects a contrast agent as the first chemical solution and physiological saline as the second chemical solution into the patient. Therefore, as shown in FIG. 2, the injector head 1 fixes the first holding unit 11 for fixing and holding the first syringe 4 filled with the contrast agent, and the second syringe 5 filled with physiological saline. And a second holding unit 12 for holding, and a support arm 14 as a support member for supporting the first holding unit 11 and the second holding unit 12. The internal mechanisms of the first holding unit 11 and the second holding unit 12 are accommodated in the covers of the first holding unit 11 and the second holding unit 12. Further, the injector head 1 includes a stirring unit 13 connected to the first holding unit 11. The internal mechanism of the stirring unit 13 is accommodated in the cover of the stirring unit 13. Then, the stirring unit 13 moves the first holding unit 11 in order to stir the contrast agent in the first syringe 4. The first drive unit 16 that pushes out the contrast agent from the first syringe 4 is provided in the first holding unit 11. A second drive unit 17 that pushes physiological saline from the second syringe 5 is provided in the second holding unit 12.
 第1保持ユニット11は、シリンジアダプタ6を有する。そして、第1シリンジ4のシリンダフランジ41がシリンジアダプタ6に保持されることにより、第1シリンジ4は第1保持ユニット11に固定される。これにより、第1シリンジ4がインジェクターヘッド1からずれてしまうことを防止できる。また、第2シリンジ5のシリンダフランジ51は、支持アーム14に設けられたシリンジアダプタ6に保持される。これにより、第2シリンジ5は、第2保持ユニット12に保持されている。これらのシリンジアダプタ6は凹部を有し、当該凹部にシリンダフランジ41,51が挿入される。そのため、第1シリンジ4及び第2シリンジ5の取り付け及び取り外しは、非常に容易である。 The first holding unit 11 has a syringe adapter 6. The first syringe 4 is fixed to the first holding unit 11 by holding the cylinder flange 41 of the first syringe 4 on the syringe adapter 6. Thereby, it can prevent that the 1st syringe 4 shifts | deviates from the injector head 1. FIG. The cylinder flange 51 of the second syringe 5 is held by the syringe adapter 6 provided on the support arm 14. Thereby, the second syringe 5 is held by the second holding unit 12. These syringe adapters 6 have a recess, and the cylinder flanges 41 and 51 are inserted into the recess. Therefore, attachment and removal of the first syringe 4 and the second syringe 5 are very easy.
 シリンジアダプタ6は、第1保持ユニット11又は支持アーム14に対して、取り外し可能に取り付けられている。そして、シリンジアダプタ6は、シリンジのサイズ又は形状に応じて交換することができる。これにより、種々のサイズ及び形状のシリンジをインジェクターヘッド1に装着することができる。また、シリンジアダプタ6は、撹拌ユニット13よりも安価であるため、シリンジに応じてシリンジアダプタ6を交換しても、ユーザーに対するコストの負担は小さい。さらに、シリンジアダプタ6は、取り外し及び取り付けが撹拌ユニット13より容易である。そのため、交換の際にオペレーターにかかる手間を小さくすることができる。 The syringe adapter 6 is detachably attached to the first holding unit 11 or the support arm 14. And the syringe adapter 6 can be replaced | exchanged according to the size or shape of a syringe. Thereby, syringes of various sizes and shapes can be attached to the injector head 1. Moreover, since the syringe adapter 6 is cheaper than the stirring unit 13, even if the syringe adapter 6 is replaced according to the syringe, the cost burden on the user is small. Further, the syringe adapter 6 is easier to remove and attach than the stirring unit 13. Therefore, it is possible to reduce the time and labor required for the operator during replacement.
 第1シリンジ4のシリンダ42は、シリンジアダプタ6と第1保持ユニット11に設けられたシリンダ受け部110とによって支持されている。また、第2シリンジ5のシリンダ52は、シリンジアダプタ6と支持アーム14に設けられたシリンダ受け部120とによって支持されている。シリンダ受け部110,120は、第1保持ユニット11又は支持アーム14から外方に向かって突出している。また、シリンダ受け部110,120は、シリンダ42,52の外形に沿った断面略U字状の形状を有しており、シリンジアダプタ6と共に交換可能である。つまり、シリンダ受け部110,120は、シリンジのサイズ又は形状に応じて交換することができる。 The cylinder 42 of the first syringe 4 is supported by the syringe adapter 6 and a cylinder receiving part 110 provided in the first holding unit 11. Further, the cylinder 52 of the second syringe 5 is supported by the syringe adapter 6 and a cylinder receiving portion 120 provided on the support arm 14. The cylinder receiving portions 110 and 120 protrude outward from the first holding unit 11 or the support arm 14. The cylinder receivers 110 and 120 have a substantially U-shaped cross section along the outer shape of the cylinders 42 and 52 and can be exchanged together with the syringe adapter 6. That is, the cylinder receiving portions 110 and 120 can be exchanged according to the size or shape of the syringe.
 第1保持ユニット11は、第1シリンジ4の外面に接触するヒーター(不図示)を有する。ヒーターは、第1保持ユニット11に設けられたシリンダ受け部110に設けられ、第1シリンジ4のシリンダ42を加熱又は保温する。このヒーターは、シリンダ受け部110上面に配置されるか、又はシリンダ受け部110に内蔵される。ヒーターによって加熱することにより、シリンダ42内の造影剤に対流が生じ、造影剤の撹拌効果をより高めることができる。この加熱は、マイクロバブルを崩壊させない程度の温度で行われる。また、ヒーターによって造影剤を保温することにより、所定の温度、例えば人間の体温程度の温度を維持することができる。 The first holding unit 11 has a heater (not shown) that contacts the outer surface of the first syringe 4. The heater is provided in a cylinder receiving part 110 provided in the first holding unit 11 and heats or keeps the cylinder 42 of the first syringe 4. This heater is arranged on the upper surface of the cylinder receiving part 110 or is built in the cylinder receiving part 110. By heating with the heater, convection occurs in the contrast medium in the cylinder 42, and the stirring effect of the contrast medium can be further enhanced. This heating is performed at a temperature that does not cause the microbubbles to collapse. Further, by keeping the contrast medium warm by a heater, a predetermined temperature, for example, a temperature about the human body temperature can be maintained.
 第1シリンジ4の先端には導管部43が設けられ、第2シリンジ5の先端には導管部53が設けられている。そして、第1シリンジ4及び第2シリンジ5の先端近傍には保持部材が配置されていない。これにより、導管部43,53が保持部材によって汚されることはない。この導管部43,53には、薬液を注入する際にチューブ9が接続される。チューブ9は、第1シリンジ4に接続される第1チューブ91と、第2シリンジ5に接続される第2チューブ92とを有する。第1チューブ91と第2チューブ92とは分岐部を介して連通している。また、チューブ9はカテーテル等に接続される先端部95を有し、先端部95には液だれキャップが取り付けられている。 A conduit portion 43 is provided at the tip of the first syringe 4, and a conduit portion 53 is provided at the tip of the second syringe 5. And the holding member is not arrange | positioned in the tip vicinity of the 1st syringe 4 and the 2nd syringe 5. FIG. Thereby, the conduit parts 43 and 53 are not soiled by the holding member. A tube 9 is connected to the conduit portions 43 and 53 when a chemical solution is injected. The tube 9 includes a first tube 91 connected to the first syringe 4 and a second tube 92 connected to the second syringe 5. The 1st tube 91 and the 2nd tube 92 are connected via the branch part. The tube 9 has a distal end portion 95 connected to a catheter or the like, and a dripping cap is attached to the distal end portion 95.
 第1チューブ91の端部には第1コネクター93が取り付けられており、第1シリンジ4の導管部43には第2コネクター94が取り付けられている。第2コネクター94は、第1コネクター93に挿入され、第1コネクター93に対して回転可能に連結される。第1実施形態においては、第1保持ユニット11が第1シリンジ4の軸線方向と交差する方向に揺動する。しかし、第2コネクター94が第1コネクター93と回転可能に連結されるため、チューブ9がねじれてしまうことはない。なお、第2コネクター94と第1コネクター93とは、螺合させることもできる。螺合させることにより、第1シリンジ4の揺動に応じてチューブ9が動いたとしても、第2コネクター94と第1コネクター93との接続が解除されることはない。 A first connector 93 is attached to the end of the first tube 91, and a second connector 94 is attached to the conduit portion 43 of the first syringe 4. The second connector 94 is inserted into the first connector 93 and is rotatably connected to the first connector 93. In the first embodiment, the first holding unit 11 swings in a direction that intersects the axial direction of the first syringe 4. However, since the second connector 94 is rotatably connected to the first connector 93, the tube 9 is not twisted. The second connector 94 and the first connector 93 can be screwed together. By screwing, even if the tube 9 moves according to the swing of the first syringe 4, the connection between the second connector 94 and the first connector 93 is not released.
 第1シリンジ4にはピストン44が取り付けられており、第2シリンジ5にはピストン54が取り付けられている。ピストン44の後端は第1駆動部16のプレッサー160に係合し、ピストン54の後端は第2駆動部17のプレッサー170に係合する。そして、プレッサー160,170は、シリンジの軸線方向において、ピストン44,54を別々に又は同時に前進又は後退させる。プレッサー160,170がシリンジの先端に向かってピストン44,54を押すと、ピストン44,54が前進してシリンダ42,52内の造影剤及び生理食塩水が押し出される。押し出された造影剤及び生理食塩水は、チューブ9と、先端部95に接続されたカテーテル等とを介して患者の血管内に注入される。なお、薬液注入は、造影剤注入後に生理食塩水を注入することが多いが、造影剤と生理食塩水とを同時に注入することもできる。 A piston 44 is attached to the first syringe 4, and a piston 54 is attached to the second syringe 5. The rear end of the piston 44 engages with the presser 160 of the first drive unit 16, and the rear end of the piston 54 engages with the presser 170 of the second drive unit 17. The pressers 160 and 170 advance or retract the pistons 44 and 54 separately or simultaneously in the axial direction of the syringe. When the pressers 160 and 170 push the pistons 44 and 54 toward the tip of the syringe, the pistons 44 and 54 move forward and the contrast medium and physiological saline in the cylinders 42 and 52 are pushed out. The extruded contrast agent and physiological saline are injected into the patient's blood vessel through the tube 9 and a catheter or the like connected to the distal end portion 95. In addition, in the chemical solution injection, physiological saline is often injected after contrast agent injection, but the contrast agent and physiological saline can also be injected simultaneously.
 血管確保を確認する場合には、チューブ9のリリースバルブ96を用いる。リリースバルブ96を押したときは、血管側から第2シリンジ5側へ液を流すことができる。そのため、プレッサー170を後退させることによりピストン54を後退させて、血液が戻ることを確認することができる。この時、第1シリンジ4から第2シリンジ5に造影剤が流入しないように、第1コネクター93内には弁が設けられている。この弁は、所定の圧力以下では開放されず、所定の圧力を越えたときに開放される。そのため、第1シリンジ4から先端部95に向かう方向にのみ液を流すことができる。リリースバルブ96内にも、薬液の注入時に第2シリンジ5から先端部95に向かう方向にのみ液が流れるように制限する弁が設けられている。血液が戻ることを確認した後には、生理食塩水を少量注入する。なお、これらの弁を設ける代わりに、第1チューブ91と第2チューブ92との分岐部に三方活栓を設けることもできる。これにより、液の流れる方向を手動又は自動で切り替えることができる。 When confirming the blood vessel, the release valve 96 of the tube 9 is used. When the release valve 96 is pushed, the liquid can flow from the blood vessel side to the second syringe 5 side. Therefore, it can be confirmed that the blood is returned by retracting the presser 170 to retract the piston 54. At this time, a valve is provided in the first connector 93 so that the contrast agent does not flow into the second syringe 5 from the first syringe 4. This valve is not opened below a predetermined pressure, and is opened when a predetermined pressure is exceeded. Therefore, the liquid can flow only in the direction from the first syringe 4 toward the distal end portion 95. The release valve 96 is also provided with a valve that restricts the liquid to flow only in the direction from the second syringe 5 toward the distal end portion 95 when the chemical liquid is injected. After confirming that the blood has returned, a small amount of physiological saline is injected. Instead of providing these valves, a three-way stopcock can be provided at the branch portion between the first tube 91 and the second tube 92. Thereby, the flow direction of a liquid can be switched manually or automatically.
 図3に示すように、インジェクターヘッド1は、薬液の注入及び撹拌を操作することができる操作部19と、インジェクターヘッド1の注入動作を制御するために、第1駆動部16、第2駆動部17及び撹拌ユニット13を制御する制御部18とを備えている。第1駆動部16は、プレッサー160を駆動する注入用モーター161と、注入用モーター161からの回転運動を直線運動に変換する変換機構162とを有する。また、第2駆動部17は、プレッサー170を駆動する注入用モーター171と、注入用モーター171からの回転運動を直線運動に変換する変換機構172とを有する。そして、撹拌ユニット13は、第1保持ユニット11を駆動する撹拌用モーター130と、撹拌用モーターからの回転運動を第1保持ユニット11に伝達する伝達機構131とを有する。 As shown in FIG. 3, the injector head 1 includes an operation unit 19 capable of operating the injection and stirring of the chemical solution, and a first drive unit 16 and a second drive unit for controlling the injection operation of the injector head 1. 17 and a control unit 18 for controlling the stirring unit 13. The first drive unit 16 includes an injection motor 161 that drives the presser 160, and a conversion mechanism 162 that converts the rotational motion from the injection motor 161 into linear motion. Further, the second drive unit 17 includes an injection motor 171 that drives the presser 170 and a conversion mechanism 172 that converts the rotational motion from the injection motor 171 into a linear motion. The stirring unit 13 includes a stirring motor 130 that drives the first holding unit 11 and a transmission mechanism 131 that transmits the rotational motion from the stirring motor to the first holding unit 11.
 第1保持ユニット11は、一対の支持アーム14,15に挟まれた状態で、第1シリンジ4の軸線方向と交差する方向、好ましくは直交する方向に揺動可能に支持されている。すなわち、第1保持ユニット11の先端側にはシャフト141が固定されており、第1保持ユニット11はシャフト141を介して支持アーム14に揺動可能に支持されている。また、第1保持ユニット11の後端側にはシャフト151が固定されており、第1保持ユニット11はシャフト151を介して支持アーム15に揺動可能に支持されている。そして、第1保持ユニット11は、第1シリンジ4のシリンダ42の中心軸を軸線として、軸線方向に揺動可能である。また、シャフト151は支持アーム15の軸穴を貫通しており、第1保持ユニット11はシャフト151を介して撹拌ユニット13の伝達機構131と接続されている。また、シャフト141はシャフト151と同軸であり、シャフト141の端部は支持アーム14の軸穴を貫通している。これにより、第1保持ユニット11は、シャフト141,151を中心に揺動可能に支持されている。一方、撹拌ユニット13は支持アーム14に固定されており、第2保持ユニット12は一対の支持アーム14,15に挟まれた状態で固定され且つ保持されている。 The first holding unit 11 is supported so as to be swingable in a direction intersecting the axial direction of the first syringe 4, preferably in a direction perpendicular to the first syringe 4, in a state sandwiched between the pair of support arms 14 and 15. That is, the shaft 141 is fixed to the distal end side of the first holding unit 11, and the first holding unit 11 is swingably supported by the support arm 14 via the shaft 141. A shaft 151 is fixed to the rear end side of the first holding unit 11, and the first holding unit 11 is swingably supported by the support arm 15 via the shaft 151. The first holding unit 11 can swing in the axial direction with the central axis of the cylinder 42 of the first syringe 4 as the axis. Further, the shaft 151 passes through the shaft hole of the support arm 15, and the first holding unit 11 is connected to the transmission mechanism 131 of the stirring unit 13 through the shaft 151. The shaft 141 is coaxial with the shaft 151, and the end of the shaft 141 passes through the shaft hole of the support arm 14. Thereby, the 1st holding | maintenance unit 11 is supported so that rocking | fluctuation centering on the shafts 141 and 151 is possible. On the other hand, the stirring unit 13 is fixed to the support arm 14, and the second holding unit 12 is fixed and held while being sandwiched between the pair of support arms 14 and 15.
 薬液を注入する場合、オペレーターは、操作部19によってインジェクターヘッド1を操作する。この場合、オペレーターは、体重等の患者の身体的データ、及び薬液の種類のデータ等を操作部19にから入力する。制御部18は、入力されたデータ等に基づいて注入速度、注入量、注入時間等の注入プロトコルを算出する。そして、インジェクターヘッド1の制御部18は、注入プロトコルに従ってインジェクターヘッド1を動作させる。例えば、オペレーターが注入開始を入力すると、制御部18は注入用モーター161,171を駆動させる。注入用モーター161,171の回転運動は、変換機構162,172により直線運動に変換され、プレッサー160,170に伝達される。そして、プレッサー160,170によって、ピストン44,54がシリンジの先端に向かって押される。これにより、ピストン44,54が前進して第1シリンジ4内の造影剤及び第2シリンジ5内の生理食塩水が押し出される。なお、図3においては、インジェクターヘッド1が操作部19と制御部18とを備えている。しかし、インジェクターヘッド1の外部に操作部19と制御部18とを設けることも可能である。この場合、インジェクターヘッド1、操作部19及び制御部18は有線又は無線によって接続され、インジェクターヘッド1を遠隔操作することができる。 When injecting a chemical solution, the operator operates the injector head 1 with the operation unit 19. In this case, the operator inputs physical data of the patient such as weight, data on the type of the chemical solution, and the like from the operation unit 19. The control unit 18 calculates an injection protocol such as an injection rate, an injection amount, and an injection time based on the input data. And the control part 18 of the injector head 1 operates the injector head 1 according to an injection | pouring protocol. For example, when the operator inputs the start of injection, the control unit 18 drives the injection motors 161 and 171. The rotational motions of the injection motors 161 and 171 are converted into linear motions by the conversion mechanisms 162 and 172 and transmitted to the pressers 160 and 170. Then, the pressers 160 and 170 push the pistons 44 and 54 toward the tip of the syringe. As a result, the pistons 44 and 54 move forward, and the contrast medium in the first syringe 4 and the physiological saline in the second syringe 5 are pushed out. In FIG. 3, the injector head 1 includes an operation unit 19 and a control unit 18. However, the operation unit 19 and the control unit 18 can be provided outside the injector head 1. In this case, the injector head 1, the operation unit 19, and the control unit 18 are connected by wire or wireless, and the injector head 1 can be remotely operated.
 オペレーターは、薬液を注入する前に造影剤の撹拌を行う。まず、オペレーターは、第1シリンジ4を第1保持ユニット11に装着する。続いて、オペレーターは、操作部19を操作して撹拌動作の開始を入力する。操作部19は、撹拌動作を開始する旨の制御信号を制御部18に送信する。制御信号を受信した制御部18は、撹拌ユニット13に予め定められた撹拌動作を行わせるために、撹拌用モーター130を駆動させる。撹拌用モーター130からの回転運動は、伝達機構131を介してシャフト151に伝達される。シャフト151は第1保持ユニット11に固定されているため、第1保持ユニット11はシャフト151の回転に従い揺動する。 The operator stirs the contrast agent before injecting the drug solution. First, the operator attaches the first syringe 4 to the first holding unit 11. Subsequently, the operator operates the operation unit 19 and inputs the start of the stirring operation. The operation unit 19 transmits a control signal for starting the stirring operation to the control unit 18. The control unit 18 that has received the control signal drives the stirring motor 130 to cause the stirring unit 13 to perform a predetermined stirring operation. The rotational motion from the stirring motor 130 is transmitted to the shaft 151 via the transmission mechanism 131. Since the shaft 151 is fixed to the first holding unit 11, the first holding unit 11 swings according to the rotation of the shaft 151.
 撹拌動作は、例えば、撹拌時間が10秒から300秒であり、回転速度が10rpmから120rpmであり、第1保持ユニット11の揺動角度が45度から360度である。また、撹拌動作は、一方向への揺動と逆方向への揺動とを繰り返すように行うことができる。この場合、例えば、第1保持ユニット11を一方向へ180度揺動させる。すなわち、第1保持ユニット11の第1シリンジ4を装着する側が下を向く位置まで、第1保持ユニット11を揺動させる。その後、第1保持ユニット11を逆方向へ180度揺動させる。すなわち、元の位置に戻るように、第1保持ユニット11を揺動させる。または、第1保持ユニット11を一方向へ45度揺動させる。その後、第1保持ユニット11を逆方向へ90度揺動させる。すなわち、元の位置を通過させて、第1保持ユニット11を逆方向へ45度揺動させる。 In the stirring operation, for example, the stirring time is 10 seconds to 300 seconds, the rotation speed is 10 rpm to 120 rpm, and the swing angle of the first holding unit 11 is 45 degrees to 360 degrees. Further, the stirring operation can be performed so as to repeat swinging in one direction and swinging in the opposite direction. In this case, for example, the first holding unit 11 is swung 180 degrees in one direction. That is, the first holding unit 11 is swung until the side where the first syringe 4 of the first holding unit 11 is attached faces downward. Thereafter, the first holding unit 11 is swung 180 degrees in the reverse direction. That is, the first holding unit 11 is swung so as to return to the original position. Alternatively, the first holding unit 11 is swung 45 degrees in one direction. Thereafter, the first holding unit 11 is swung 90 degrees in the reverse direction. That is, the first holding unit 11 is swung 45 degrees in the reverse direction through the original position.
 なお、撹拌動作は、造影剤の分離が検知されたときに自動で開始させることもできる。この造影剤の分離は、CCDカメラ又はセンサー等によって検知することができる。例えば、CCDカメラの場合、シリンダ42内の造影剤の画像をCCDカメラにより撮影し、撮影した画像から造影剤の分離を認識させることができる。さらに、所定の時間ごとに、自動で撹拌動作を行うように設定することもできる。 It should be noted that the stirring operation can be automatically started when the separation of the contrast agent is detected. The separation of the contrast agent can be detected by a CCD camera or a sensor. For example, in the case of a CCD camera, an image of the contrast agent in the cylinder 42 can be taken by the CCD camera, and the separation of the contrast agent can be recognized from the taken image. Furthermore, it can be set so that the stirring operation is automatically performed every predetermined time.
 また制御部18は、撹拌動作中に注入を開始しないように制御する。すなわち、制御部18は、第1保持ユニット11の揺動が停止した後に薬液の注入を開始する。そのため、制御部18が撹拌動作中に注入開始の信号を受信した場合、制御部18は撹拌動作の終了を待って注入用モーター161,171を駆動させる。これにより、第1保持ユニット11の揺動によりチューブ9が動くことはなく、注入中に患者からカテーテル等が外れてしまうことを防止できる。なお、制御部18は、注入を開始する際に、撹拌ユニット13に撹拌動作を行わせることもできる。この場合、注入開始の制御信号を受信した制御部18は、撹拌ユニット13に撹拌動作を行わせ、撹拌動作が終了した後に注入用モーター161,171を駆動する。なお、第1実施形態では、制御部18が撹拌動作中に注入を開始しないように制御しているが、注入中に撹拌動作を行うことも可能である。 Further, the control unit 18 performs control so as not to start injection during the stirring operation. That is, the control unit 18 starts injecting the chemical liquid after the first holding unit 11 stops swinging. Therefore, when the control unit 18 receives an injection start signal during the stirring operation, the control unit 18 drives the injection motors 161 and 171 after waiting for the stirring operation to end. Thereby, the tube 9 does not move due to the swinging of the first holding unit 11, and it is possible to prevent the catheter or the like from being detached from the patient during the injection. In addition, the control part 18 can also make the stirring unit 13 perform stirring operation, when starting injection | pouring. In this case, the control unit 18 that has received the injection start control signal causes the stirring unit 13 to perform the stirring operation, and drives the injection motors 161 and 171 after the stirring operation is completed. In the first embodiment, the control unit 18 performs control so that the injection is not started during the stirring operation. However, the stirring operation can be performed during the injection.
 次に図4を参照して、第1駆動部16及び第2駆動部17について説明する。第1駆動部16は第1保持ユニット11のカバー内に配置されており、第2駆動部17は第2保持ユニット12のカバー内に配置されている。第1駆動部16及び第2駆動部17は、それぞれ注入用モーター161,171と、変換機構162,172とを有する。注入用モーター161,171は、例えばステッピングモーターである。変換機構162,172は、ボールねじ163,173と、プレッサーとして機能するボールナットユニット160,170とを有している。また、第1保持ユニット11は、先端側に位置する先端部材114と、後端側に位置する後端部材115と、先端部材114及び後端部材115を連結する梁部材116とを含むフレームを有する。 Next, the first drive unit 16 and the second drive unit 17 will be described with reference to FIG. The first drive unit 16 is arranged in the cover of the first holding unit 11, and the second drive unit 17 is arranged in the cover of the second holding unit 12. The first drive unit 16 and the second drive unit 17 have injection motors 161 and 171 and conversion mechanisms 162 and 172, respectively. The injection motors 161 and 171 are, for example, stepping motors. The conversion mechanisms 162 and 172 include ball screws 163 and 173 and ball nut units 160 and 170 that function as a presser. The first holding unit 11 includes a frame including a front end member 114 located on the front end side, a rear end member 115 located on the rear end side, and a beam member 116 that connects the front end member 114 and the rear end member 115. Have.
 ボールねじ163,173は、2つのプーリー及びベルト(不図示)を介して注入用モーター161,171の出力軸に連結されている。そして、一方のプーリーは注入用モーター161,171の出力軸に固定されており、他方のプーリーはボールねじ163,173の端部に固定されている。2つのプーリーにはベルトが掛け回されており、注入用モーター161,171の回転運動はボールねじ163,173に伝達される。なお、2つのプーリー及びベルトに代えて、歯車によってボールねじ163,173に回転運動を伝達してもよい。 The ball screws 163 and 173 are connected to the output shafts of the injection motors 161 and 171 via two pulleys and a belt (not shown). One pulley is fixed to the output shafts of the injection motors 161 and 171, and the other pulley is fixed to the ends of the ball screws 163 and 173. Belts are wound around the two pulleys, and the rotational movements of the injection motors 161 and 171 are transmitted to the ball screws 163 and 173. Instead of the two pulleys and the belt, the rotational motion may be transmitted to the ball screws 163 and 173 by a gear.
 第1駆動部16のボールねじ163は、フレームの先端部材114と後端部材115とに回転自在かつ軸方向に移動不能に支持されている。そして、ボールナットユニット160を貫通するガイドシャフト165が、先端部材114及び後端部材115に固定されている。また、第2駆動部17のボールねじ173は、支持アーム14,15に回転自在かつ軸方向に移動不能に支持されている。そして、ボールナットユニット170を貫通するガイドシャフト175が、支持アーム14,15に固定されている。ボールナットユニット160,170は、ボールねじ163,173に螺合している。 The ball screw 163 of the first driving unit 16 is supported by the front end member 114 and the rear end member 115 of the frame so as to be rotatable and immovable in the axial direction. A guide shaft 165 passing through the ball nut unit 160 is fixed to the front end member 114 and the rear end member 115. The ball screw 173 of the second drive unit 17 is supported by the support arms 14 and 15 so as to be rotatable and immovable in the axial direction. A guide shaft 175 that passes through the ball nut unit 170 is fixed to the support arms 14 and 15. The ball nut units 160 and 170 are screwed into the ball screws 163 and 173.
 ボールナットユニット160,170は、ボールねじ163,173の回転に伴いガイドシャフト165,175に沿って直線運動する。具体的には、注入用モーター161,171を駆動すると、プーリー及びベルトを介して回転運動がボールねじ163,173に伝達され、ボールねじ163,173が回転する。ボールねじ163,173が回転すると、回転方向に応じてボールナットユニット160,170がボールねじ163,173に沿って前進又は後退する。また、ボールナットユニット160,170には、係合部164,174を介してピストン44,54の後端が係合され且つ保持されている。そのため、ボールナットユニット160,170の摺動によりピストン44,54が押されると、ピストン44,54は前進する。また、ボールナットユニット160,170の摺動によりピストン44,54が引かれると、ピストン44,54は後進する。 The ball nut units 160 and 170 linearly move along the guide shafts 165 and 175 as the ball screws 163 and 173 rotate. Specifically, when the injection motors 161 and 171 are driven, the rotational motion is transmitted to the ball screws 163 and 173 via the pulleys and the belt, and the ball screws 163 and 173 rotate. When the ball screws 163 and 173 rotate, the ball nut units 160 and 170 move forward or backward along the ball screws 163 and 173 according to the rotation direction. Further, the rear ends of the pistons 44 and 54 are engaged with and held by the ball nut units 160 and 170 via the engaging portions 164 and 174. Therefore, when the pistons 44 and 54 are pushed by the sliding of the ball nut units 160 and 170, the pistons 44 and 54 move forward. Further, when the pistons 44 and 54 are pulled by the sliding of the ball nut units 160 and 170, the pistons 44 and 54 move backward.
 次に、図4及び図5を参照して撹拌ユニット13について説明する。なお、説明の便宜のため、図4の四角枠内には撹拌ユニット13の伝達機構131を抜き出して図示している。撹拌ユニット13は、撹拌用モーター130と、撹拌用モーター130からの回転力をシャフト151に伝達する伝達機構131とを有する。撹拌用モーター130は、例えばステッピングモーターである。そして、第1保持ユニット11は、シャフト151を介して伝達機構131に接続されている。この伝達機構131は、第1ギア132、第2ギア133、第3ギア134及び第4ギア135と、ベルト136とを有する。第1ギア132は撹拌用モーター130の出力軸に接続され且つ固定されており、第2ギア133は第1ギア132の外歯と噛み合う外歯を有する。第3ギア134は、第2ギア133と同軸であり、第2ギア133に対してボルト留めされ且つ固定されている。また、第3ギア134及び第4ギア135はベルト136の内歯と噛み合う外歯を有する。そして、第4ギア135はシャフト151に固定されており、シャフト151は第1保持ユニット11の後端部材115に固定されている。 Next, the stirring unit 13 will be described with reference to FIGS. For convenience of explanation, the transmission mechanism 131 of the stirring unit 13 is extracted and shown in the square frame of FIG. The stirring unit 13 includes a stirring motor 130 and a transmission mechanism 131 that transmits the rotational force from the stirring motor 130 to the shaft 151. The stirring motor 130 is, for example, a stepping motor. The first holding unit 11 is connected to the transmission mechanism 131 via the shaft 151. The transmission mechanism 131 includes a first gear 132, a second gear 133, a third gear 134, a fourth gear 135, and a belt 136. The first gear 132 is connected to and fixed to the output shaft of the stirring motor 130, and the second gear 133 has external teeth that mesh with the external teeth of the first gear 132. The third gear 134 is coaxial with the second gear 133 and is bolted and fixed to the second gear 133. The third gear 134 and the fourth gear 135 have external teeth that mesh with the internal teeth of the belt 136. The fourth gear 135 is fixed to the shaft 151, and the shaft 151 is fixed to the rear end member 115 of the first holding unit 11.
 撹拌用モーター130からの回転運動は、出力軸を介して第1ギア132に伝達される。そして、第1ギア132が出力軸の回転に従い回転すると、第2ギア133が第1ギア132の回転に従い回転する。第2ギア133に固定された第3ギア134は、第2ギア133の回転に従いシャフト152を中心に回転する。第3ギア134の外歯と噛み合う内歯を有するベルト136は、第3ギア134の回転に従い回転する。そして、ベルト136の内歯と噛み合う外歯を有する第4ギア135は、ベルト136の回転に従い回転する。第4ギア135にはシャフト151が固定されているため、シャフト151は、第4ギア135の回転に従い回転する。また、シャフト151は、第1保持ユニット11の後端部材115に固定されている。そのため、シャフト151の回転に従い、第1保持ユニット11は、支持アーム14,15に対してシャフト151を中心に揺動する。 Rotational motion from the stirring motor 130 is transmitted to the first gear 132 via the output shaft. When the first gear 132 rotates according to the rotation of the output shaft, the second gear 133 rotates according to the rotation of the first gear 132. The third gear 134 fixed to the second gear 133 rotates around the shaft 152 as the second gear 133 rotates. The belt 136 having the internal teeth that mesh with the external teeth of the third gear 134 rotates according to the rotation of the third gear 134. The fourth gear 135 having external teeth that mesh with the internal teeth of the belt 136 rotates according to the rotation of the belt 136. Since the shaft 151 is fixed to the fourth gear 135, the shaft 151 rotates according to the rotation of the fourth gear 135. The shaft 151 is fixed to the rear end member 115 of the first holding unit 11. Therefore, according to the rotation of the shaft 151, the first holding unit 11 swings around the shaft 151 with respect to the support arms 14 and 15.
 ここで、撹拌用モーター130は、所定の揺動角度で第1保持ユニット11を揺動させるように制御部18に制御される。すなわち、撹拌用モーター130は、第1保持ユニット11がシャフト151の中心軸に対して水平な方向から所定の角度の範囲で往復して揺動するように制御される。そのため、第1保持ユニット11に保持され且つ固定された第1シリンジ4も、第1保持ユニット11と共に揺動する。これにより、第1シリンジ4内の造影剤が撹拌される。 Here, the stirring motor 130 is controlled by the control unit 18 so as to swing the first holding unit 11 at a predetermined swing angle. That is, the stirring motor 130 is controlled so that the first holding unit 11 reciprocates within a predetermined angle range from a horizontal direction with respect to the central axis of the shaft 151. Therefore, the first syringe 4 held and fixed by the first holding unit 11 also swings together with the first holding unit 11. Thereby, the contrast agent in the 1st syringe 4 is stirred.
 インジェクターヘッド1は、第1保持ユニット11と第2保持ユニット12とを備える二筒式インジェクターに用いられる。そのため、一方の保持ユニットとしての第2保持ユニット12をベースとして、他方の保持ユニットとしての第1保持ユニット11に保持された第1シリンジ4を揺動することにより、造影剤を撹拌することができる。このような二筒式インジェクターの場合、撹拌された造影剤を生理食塩水によってまとめて押し流しながら注入できるという利点がある。例えば、肝臓のダイナミック検査では、造影剤をまとめて注入することが好ましく、生理食塩水によって造影剤を一度に心臓へ流し込む必要がある。このような場合に、上記インジェクターヘッド1は好適に用いることができる。すなわち、注入部位から心臓までの間における造影剤の滞留が生じず、撮像された画像の品質に悪影響を与えるおそれがない。なお、注入方法としては、造影剤の注入に続いて生理食塩水を注入した後に、造影剤の注入と生理食塩水の注入を再び行う場合もできる。これにより、検査を2回行うこともできる。 The injector head 1 is used in a two-cylinder injector including a first holding unit 11 and a second holding unit 12. Therefore, the contrast agent can be agitated by swinging the first syringe 4 held by the first holding unit 11 as the other holding unit with the second holding unit 12 as one holding unit as a base. it can. In the case of such a two-cylinder injector, there is an advantage that the agitated contrast agent can be injected while being swept together with physiological saline. For example, in a dynamic examination of the liver, it is preferable to inject contrast agents together, and the contrast agent needs to be poured into the heart at once by physiological saline. In such a case, the injector head 1 can be suitably used. That is, the contrast agent does not stay between the injection site and the heart, and there is no possibility of adversely affecting the quality of the captured image. As an injection method, it is possible to inject contrast medium and physiological saline again after injecting physiological saline followed by injection of contrast medium. As a result, the inspection can be performed twice.
 第1実施形態では、シリンジを固定し且つ保持する保持ユニットを撹拌ユニットにより揺動することによって、シリンジ内の薬液が攪拌される。つまり、シリンジは、保持ユニットに固定された状態で保持ユニットと共に揺動する。これにより、撹拌動作を行っても、シリンジがずれてしまうことを防止できる。また、シリンジの取り付け及び取り外しは容易であり、撹拌ユニットを交換せずに、安価且つ容易に異なる種類のシリンジを装着することができる。さらに、シリンジの先端部分の近傍には保持部材が配置されていない。そのため、シリンジの先端部分が清潔な状態に維持される。 In the first embodiment, the chemical solution in the syringe is agitated by swinging the holding unit that fixes and holds the syringe by the agitation unit. That is, the syringe swings together with the holding unit while being fixed to the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean.
[第2実施形態]
 次に、図6を参照して第2実施形態に係るインジェクターに付いて説明する。第1実施形態のインジェクターでは、第1保持ユニット11を第1シリンジ4の軸線方向と交差する方向に揺動させた。しかし、第2実施形態のインジェクターでは、第1保持ユニット11は、第1シリンジ4の軸線方向に沿った方向に揺動する。なお、第2実施形態の説明においては、第1実施形態との相違点について説明し、第1実施形態で説明した構成要素については同じ参照番号を付し、その説明を省略する。特に説明した場合を除き、同じ参照符号を付した構成要素は略同一の動作及び機能を奏し、その作用効果も略同一である。
[Second Embodiment]
Next, an injector according to the second embodiment will be described with reference to FIG. In the injector of the first embodiment, the first holding unit 11 is swung in a direction intersecting with the axial direction of the first syringe 4. However, in the injector of the second embodiment, the first holding unit 11 swings in a direction along the axial direction of the first syringe 4. In the description of the second embodiment, differences from the first embodiment will be described, the same reference numerals will be given to the components described in the first embodiment, and description thereof will be omitted. Except where specifically described, the constituent elements having the same reference numerals perform substantially the same operations and functions, and the effects thereof are also substantially the same.
 第1実施形態とは異なり、支持アーム14,15同士の間には、ビーム216,217が設けられている。そして、第1保持ユニット11は、ビーム216,217に対して、シャフト241,251を介して揺動可能に支持されている。撹拌ユニット13側のシャフト241は、ビーム217の軸穴を貫通して伝達機構131に接続され且つ固定されている。また、第2保持ユニット12側のシャフト251は、ビーム216に形成された軸穴を貫通している。第2保持ユニット12及び撹拌ユニット13は、支持アーム14,15同士の間に配置されており、支持アーム14,15に固定されている。 Unlike the first embodiment, beams 216 and 217 are provided between the support arms 14 and 15. The first holding unit 11 is supported so as to be swingable with respect to the beams 216 and 217 via shafts 241 and 251. The shaft 241 on the stirring unit 13 side passes through the shaft hole of the beam 217 and is connected and fixed to the transmission mechanism 131. Further, the shaft 251 on the second holding unit 12 side passes through the shaft hole formed in the beam 216. The second holding unit 12 and the stirring unit 13 are arranged between the support arms 14 and 15 and are fixed to the support arms 14 and 15.
 第1実施形態と同様に、撹拌ユニット13は、撹拌用モーター130と伝達機構131とを有する。そして、撹拌用モーター130からの回転運動は、出力軸を介して伝達機構131の第1ギア132に伝達される。第1ギア132が出力軸の回転に従い回転すると、第2ギア133、第3ギア134、及びベルト136を介して、第4ギア135が回転する。第4ギア135にはシャフト241が固定されているため、第4ギア135の回転に従いシャフト241が回転する。シャフト241は前述した第1保持ユニット11の梁部材116に固定されているため、シャフト241の回転に従い第1保持ユニット11が揺動する。これにより、第1保持ユニット11に固定され且つ保持された第1シリンジ4内の造影剤が撹拌される。 As in the first embodiment, the stirring unit 13 includes a stirring motor 130 and a transmission mechanism 131. The rotational motion from the stirring motor 130 is transmitted to the first gear 132 of the transmission mechanism 131 via the output shaft. When the first gear 132 rotates according to the rotation of the output shaft, the fourth gear 135 rotates via the second gear 133, the third gear 134, and the belt 136. Since the shaft 241 is fixed to the fourth gear 135, the shaft 241 rotates according to the rotation of the fourth gear 135. Since the shaft 241 is fixed to the beam member 116 of the first holding unit 11 described above, the first holding unit 11 swings as the shaft 241 rotates. Thereby, the contrast agent in the 1st syringe 4 fixed and hold | maintained at the 1st holding | maintenance unit 11 is stirred.
 第2実施形態においても、シリンジを固定し且つ保持する保持ユニットを撹拌ユニットにより揺動することによって、シリンジ内の薬液が攪拌される。つまり、シリンジは、保持ユニットに固定された状態で保持ユニットと共に揺動する。これにより、撹拌動作を行っても、シリンジがずれてしまうことを防止できる。また、シリンジの取り付け及び取り外しは容易であり、撹拌ユニットを交換せずに、安価且つ容易に異なる種類のシリンジを装着することができる。さらに、シリンジの先端部分の近傍には保持部材が配置されていない。そのため、シリンジの先端部分が清潔な状態に維持される。 Also in the second embodiment, the chemical solution in the syringe is stirred by swinging the holding unit that fixes and holds the syringe by the stirring unit. That is, the syringe swings together with the holding unit while being fixed to the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean.
[第3実施形態]
 次に、図7を参照して第3実施形態に係るインジェクターに付いて説明する。第1及び第2実施形態のインジェクターでは、第1保持ユニット11を揺動させた。しかし、第3実施形態のインジェクターでは、第1保持ユニット11が、第1シリンジ4の軸線方向に沿った方向に摺動する。なお、第3実施形態の説明においては、第1及び第2実施形態との相違点について説明し、第1及び第2実施形態で説明した構成要素については同じ参照番号を付し、その説明を省略する。特に説明した場合を除き、同じ参照符号を付した構成要素は略同一の動作及び機能を奏し、その作用効果も略同一である。
[Third Embodiment]
Next, an injector according to the third embodiment will be described with reference to FIG. In the injectors of the first and second embodiments, the first holding unit 11 is swung. However, in the injector of the third embodiment, the first holding unit 11 slides in a direction along the axial direction of the first syringe 4. In the description of the third embodiment, differences from the first and second embodiments will be described, and the same reference numerals will be given to the components described in the first and second embodiments, and the description thereof will be made. Omitted. Except where specifically described, the constituent elements having the same reference numerals perform substantially the same operations and functions, and the effects thereof are also substantially the same.
 第1及び第2実施形態とは異なり、撹拌ユニット13は、撹拌用モーター130と、撹拌用モーター130に接続されたリンク機構331とを有する。そして、第1保持ユニット11は、リンク機構331に接続されている。リンク機構331は、撹拌用モーター130の出力軸に固定されたディスク332と、ディスク332の回転軸からずれた位置でピンを介してディスク332に接続されたロッド333とを有する。第1保持ユニット11のフレームは、先端部材314及び後端部材315と、先端部材314と後端部材315の間に位置する梁部材316とを有する。梁部材316は、先端部材314及び後端部材315にボルトによって固定されている。そして、ロッド333の端部は、梁部材316から突出したスライダ334にピンを介して接続されている。また、先端部材314は、2本のスライドシャフト317を介してカバー318に接続されている。先端部材314、後端部材315、及び梁部材316は、カバー318内で第1シリンジ4の軸線方向に直線的に摺動可能である。すなわち、先端部材314は、スライダシャフト317に対して進退自在に接続されている。 Unlike the first and second embodiments, the stirring unit 13 includes a stirring motor 130 and a link mechanism 331 connected to the stirring motor 130. The first holding unit 11 is connected to the link mechanism 331. The link mechanism 331 includes a disk 332 fixed to the output shaft of the stirring motor 130 and a rod 333 connected to the disk 332 via a pin at a position shifted from the rotation axis of the disk 332. The frame of the first holding unit 11 includes a front end member 314 and a rear end member 315, and a beam member 316 positioned between the front end member 314 and the rear end member 315. The beam member 316 is fixed to the front end member 314 and the rear end member 315 by bolts. The end of the rod 333 is connected to a slider 334 protruding from the beam member 316 via a pin. The tip member 314 is connected to the cover 318 via two slide shafts 317. The front end member 314, the rear end member 315, and the beam member 316 can slide linearly in the axial direction of the first syringe 4 within the cover 318. That is, the tip member 314 is connected to the slider shaft 317 so as to be able to advance and retract.
 撹拌動作を行う場合、制御部18は撹拌用モーター130を駆動させる。撹拌用モーター130が駆動すると、出力軸に接続されたディスク332が回転する。ディスク332の回転に従い、ディスク332に接続されたロッド333が連動する。そして、スライダ334は、ロッド333の動きに従い、第1シリンジ4の軸線方向において直線的な往復運動を行う。このスライダ334の摺動に従って、第1保持ユニット11が第1シリンジ4の軸線方向において直線的な往復運動を行う。第1保持ユニット11には、第1シリンジ4が固定され且つ保持されている。そのため、第1シリンジ4は、第1保持ユニット11の摺動に従って、図7の矢印Aで示すように直線的な往復運動を行う。これにより、第1シリンジ4内の造影剤を撹拌することができる。 When the stirring operation is performed, the control unit 18 drives the stirring motor 130. When the stirring motor 130 is driven, the disk 332 connected to the output shaft rotates. The rod 333 connected to the disk 332 is interlocked with the rotation of the disk 332. The slider 334 reciprocates linearly in the axial direction of the first syringe 4 according to the movement of the rod 333. As the slider 334 slides, the first holding unit 11 performs a linear reciprocating motion in the axial direction of the first syringe 4. The first syringe 4 is fixed and held in the first holding unit 11. Therefore, the first syringe 4 performs a linear reciprocating motion as indicated by an arrow A in FIG. 7 as the first holding unit 11 slides. Thereby, the contrast agent in the 1st syringe 4 can be stirred.
 第3実施形態においては、シリンジを固定し且つ保持する保持ユニットを撹拌ユニットによって摺動させることにより、シリンジ内の薬液が攪拌される。つまり、シリンジは、保持ユニットに固定された状態で保持ユニットと共に摺動する。これにより、撹拌動作を行っても、シリンジがずれてしまうことを防止できる。また、シリンジの取り付け及び取り外しは容易であり、撹拌ユニットを交換せずに、安価且つ容易に異なる種類のシリンジを装着することができる。さらに、シリンジの先端部分の近傍には保持部材が配置されていない。そのため、シリンジの先端部分が清潔な状態に維持される。 In the third embodiment, the drug solution in the syringe is stirred by sliding the holding unit that holds and holds the syringe with the stirring unit. That is, the syringe slides together with the holding unit while being fixed to the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean.
[第4実施形態]
 次に、図8を参照して第4実施形態に係るインジェクターに付いて説明する。第1乃至第3実施形態のインジェクターでは、第1保持ユニット11を揺動又は摺動をさせた。しかし、第4実施形態のインジェクターでは、第1保持ユニット11を動かす代わりに、保持ユニットに固定され且つ保持されたシリンジを動かす。なお、第4実施形態の説明においては、第1乃至第3実施形態との相違点について説明し、第1乃至第3実施形態で説明した構成要素については同じ参照番号を付し、その説明を省略する。特に説明した場合を除き、同じ参照符号を付した構成要素は略同一の動作及び機能を奏し、その作用効果も略同一である。
[Fourth Embodiment]
Next, an injector according to the fourth embodiment will be described with reference to FIG. In the injectors of the first to third embodiments, the first holding unit 11 is swung or slid. However, in the injector of the fourth embodiment, instead of moving the first holding unit 11, the syringe fixed and held by the holding unit is moved. In the description of the fourth embodiment, differences from the first to third embodiments will be described, and the same reference numerals will be given to the components described in the first to third embodiments, and the description thereof will be made. Omitted. Except where specifically described, the constituent elements having the same reference numerals perform substantially the same operations and functions, and the effects thereof are also substantially the same.
 第4実施形態の薬液を注入するインジェクター1も、薬液が充填された第1シリンジ4から薬液としての造影剤を押し出す第1駆動部16と、第1シリンジ4を固定し且つ保持する第1保持ユニット11と、第1保持ユニット11を支持する支持アーム14とを備える。そして、第1乃至第3実施形態とは異なり、インジェクター1は、第1シリンジ4内の薬液を撹拌するために、第1シリンジ4を動かす撹拌ユニット13を備える。すなわち、撹拌ユニット13としての振動ボックス430が、第1保持ユニット11から離間した位置において第1シリンジ4の外面に接触している。振動ボックス430は、第1シリンジ4の上面に接触し、第1シリンジ4に振動を加える。 The injector 1 for injecting the chemical solution of the fourth embodiment also has a first drive unit 16 that pushes out the contrast medium as the chemical solution from the first syringe 4 filled with the chemical solution, and a first holding that fixes and holds the first syringe 4. A unit 11 and a support arm 14 that supports the first holding unit 11 are provided. And unlike 1st thru | or 3rd embodiment, the injector 1 is provided with the stirring unit 13 which moves the 1st syringe 4 in order to stir the chemical | medical solution in the 1st syringe 4. FIG. That is, the vibration box 430 as the stirring unit 13 is in contact with the outer surface of the first syringe 4 at a position separated from the first holding unit 11. The vibration box 430 is in contact with the upper surface of the first syringe 4 and applies vibration to the first syringe 4.
 撹拌ユニット13は、振動ボックス430内に撹拌モーターとしての振動モーターを有している。そして、振動モーターは制御部18により駆動され、振動が第1シリンジ4に伝達される。これにより、第1シリンジ4内の造影剤が撹拌される。また、振動ボックス430は、軸を中心に揺動可能な揺動アーム431によって支持されている。そして、揺動アーム431は、軸を介して第1保持ユニット11の先端部材314又は不図示の支持アーム14に接続されている。そのため、揺動アーム431及び振動ボックス430は、接触位置と退避位置との間で揺動可能である。そして、揺動アーム431は、図8に示す接触位置においては、不図示のロック手段で固定される。また、振動ボックス430は、接触位置において第1シリンジ4の上面に接触する。 The stirring unit 13 has a vibration motor as a stirring motor in the vibration box 430. The vibration motor is driven by the control unit 18, and vibration is transmitted to the first syringe 4. Thereby, the contrast agent in the 1st syringe 4 is stirred. The vibration box 430 is supported by a swing arm 431 that can swing around an axis. The swing arm 431 is connected to the tip member 314 of the first holding unit 11 or the support arm 14 (not shown) via a shaft. Therefore, the swing arm 431 and the vibration box 430 can swing between the contact position and the retracted position. The swing arm 431 is fixed by a lock means (not shown) at the contact position shown in FIG. Moreover, the vibration box 430 contacts the upper surface of the first syringe 4 at the contact position.
 一方、振動ボックス430は、退避触位置においては、第1シリンジ4から離間している。そして、第1シリンジ4を第1保持ユニット11に装着させる、又は第1保持ユニット11取り外す際には、揺動アーム431のロックを解除した後に揺動させ、図8の矢印Bで示す方向に退避位置まで退避させる。なお、振動ボックス430は、第1シリンジ4の下面又は側面に接触させることもできる。この場合、例えば、揺動アーム431は、第1シリンジ4の下方の接触位置と、退避位置との間で揺動可能となるように構成される。 On the other hand, the vibration box 430 is separated from the first syringe 4 in the retracted touch position. When attaching the first syringe 4 to the first holding unit 11 or removing the first holding unit 11, the first arm 4 is swung after the rocking arm 431 is unlocked and moved in the direction indicated by the arrow B in FIG. 8. Retreat to the retreat position. Note that the vibration box 430 can be brought into contact with the lower surface or the side surface of the first syringe 4. In this case, for example, the swing arm 431 is configured to be swingable between a contact position below the first syringe 4 and a retracted position.
 第4実施形態においては、保持ユニットに固定され且つ保持されたシリンジに撹拌ユニットが振動を加えることにより、シリンジ内の薬液が攪拌される。つまり、シリンジは、保持ユニットに固定され且つ保持された状態で振動する。これにより、撹拌動作を行っても、シリンジがずれてしまうことを防止できる。また、シリンジの取り付け及び取り外しは容易であり、撹拌ユニットを交換せずに、安価且つ容易に異なる種類のシリンジを装着することができる。さらに、シリンジの先端部分の近傍には保持部材が配置されていない。そのため、シリンジの先端部分が清潔な状態に維持される。 In the fourth embodiment, the chemical solution in the syringe is stirred by the stirring unit applying vibration to the syringe fixed and held by the holding unit. That is, the syringe vibrates while being fixed to and held by the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean.
[第5実施形態]
 次に、図9を参照して第5実施形態に係るインジェクターに付いて説明する。第1実施形態のインジェクターでは、第1保持ユニット11の先端側に支持アーム14が設けられ、第1保持ユニット11の後端側に支持アーム15が設けられていた。しかし、第5実施形態のインジェクターでは、第1保持ユニット11を支持する支持部材が、第1保持ユニット11の先端側を避けて配置されている。なお、第5実施形態の説明においては、第1実施形態との相違点について説明し、第1実施形態で説明した構成要素については同じ参照番号を付し、その説明を省略する。特に説明した場合を除き、同じ参照符号を付した構成要素は略同一の動作及び機能を奏し、その作用効果も略同一である。
[Fifth Embodiment]
Next, an injector according to a fifth embodiment will be described with reference to FIG. In the injector of the first embodiment, the support arm 14 is provided on the front end side of the first holding unit 11, and the support arm 15 is provided on the rear end side of the first holding unit 11. However, in the injector according to the fifth embodiment, the support member that supports the first holding unit 11 is disposed so as to avoid the distal end side of the first holding unit 11. In the description of the fifth embodiment, differences from the first embodiment will be described, and the same reference numerals will be given to the components described in the first embodiment, and description thereof will be omitted. Except where specifically described, the constituent elements having the same reference numerals perform substantially the same operations and functions, and the effects thereof are also substantially the same.
 第1実施形態と同様に、インジェクターヘッド1には、第1保持ユニット11、第2保持ユニット12、及び撹拌ユニット13が設けられている。撹拌ユニット13内には、支持部材としての支持アーム15(不図示)が配置されている。そして、第1実施形態とは異なり、第1保持ユニット11の後端側のみが、シャフト151を介して支持アーム15によって支持されている。すなわち、支持アーム14が設けられておらず、第1保持ユニット11の先端側は自由端となっている。そのため、撹拌動作の際に、第1シリンジ4が支持アーム14に接触するおそれがない。これにより、撹拌動作の自由度を高めることができる。 As in the first embodiment, the injector head 1 is provided with a first holding unit 11, a second holding unit 12, and a stirring unit 13. A support arm 15 (not shown) as a support member is disposed in the stirring unit 13. Unlike the first embodiment, only the rear end side of the first holding unit 11 is supported by the support arm 15 via the shaft 151. That is, the support arm 14 is not provided, and the distal end side of the first holding unit 11 is a free end. Therefore, there is no possibility that the first syringe 4 contacts the support arm 14 during the stirring operation. Thereby, the freedom degree of stirring operation can be raised.
 例えば、第5実施形態の撹拌動作は、第1保持ユニット11を一方向へ所定の時間回転させるように行うことができる。また、撹拌動作は、以下のように行うこともできる。まず、第1保持ユニット11を一方向へ180度揺動させる。すなわち、第1保持ユニット11の第1シリンジ4を装着する側が下を向く位置まで、第1保持ユニット11を揺動させる。その後、第1保持ユニット11を逆方向へ360度揺動させる。すなわち、元の位置を通過して第1シリンジ4を装着する側が下を向く位置まで、第1保持ユニット11を逆方向に揺動させる。なお、撹拌動作は、第1実施形態と同様に行うこともできる。 For example, the stirring operation of the fifth embodiment can be performed so as to rotate the first holding unit 11 in one direction for a predetermined time. Moreover, stirring operation can also be performed as follows. First, the first holding unit 11 is swung 180 degrees in one direction. That is, the first holding unit 11 is swung until the side where the first syringe 4 of the first holding unit 11 is attached faces downward. Thereafter, the first holding unit 11 is swung 360 degrees in the reverse direction. That is, the first holding unit 11 is swung in the reverse direction until it passes through the original position and the side on which the first syringe 4 is mounted faces downward. The stirring operation can be performed in the same manner as in the first embodiment.
 第1実施形態と同様に、撹拌ユニット13は、撹拌用モーター130と伝達機構131とを有する。そして、撹拌用モーター130からの回転運動は、出力軸を介して伝達機構131の第1ギア132に伝達される。第1ギア132が出力軸の回転に従い回転すると、第2ギア133、第3ギア134、及びベルト136を介して、第4ギア135が回転する。第4ギア135にはシャフト151が固定されているため、第4ギア135の回転に従いシャフト151が回転する。シャフト151は第1保持ユニット11の後端部材115に固定されているため、シャフト151の回転に従い第1保持ユニット11が揺動する。これにより、第1保持ユニット11に固定され且つ保持された第1シリンジ4内の造影剤が撹拌される。 As in the first embodiment, the stirring unit 13 includes a stirring motor 130 and a transmission mechanism 131. The rotational motion from the stirring motor 130 is transmitted to the first gear 132 of the transmission mechanism 131 via the output shaft. When the first gear 132 rotates according to the rotation of the output shaft, the fourth gear 135 rotates via the second gear 133, the third gear 134, and the belt 136. Since the shaft 151 is fixed to the fourth gear 135, the shaft 151 rotates according to the rotation of the fourth gear 135. Since the shaft 151 is fixed to the rear end member 115 of the first holding unit 11, the first holding unit 11 swings as the shaft 151 rotates. Thereby, the contrast agent in the 1st syringe 4 fixed and hold | maintained at the 1st holding | maintenance unit 11 is stirred.
 また、第1保持ユニット11と撹拌ユニット13とは、所定の距離だけ離間している。これにより、第1保持ユニット11の揺動中に、オペレーターの指が誤って挟まれる又は揺動に巻き込まれることを防止できる。さらに、第1保持ユニット11は、透明なカバーで覆うこともできる。このカバーは、第1保持ユニット11の揺動を制限しないように、カバーの先端側が開口している。そして、カバーの内側空間は、揺動する第1保持ユニット11と接触しないような大きさで構成されている。これにより、第1保持ユニット11の上面側、側面側及び下面側を覆うことができるので、オペレーターの指が挟まれる又は巻き込まれることを防止できる。 Further, the first holding unit 11 and the stirring unit 13 are separated by a predetermined distance. Thereby, it is possible to prevent the operator's finger from being accidentally pinched or caught in the swing while the first holding unit 11 is swinging. Further, the first holding unit 11 can be covered with a transparent cover. The cover has an open front end so as not to limit the swing of the first holding unit 11. The inner space of the cover is configured so as not to come into contact with the swinging first holding unit 11. Thereby, since the upper surface side, side surface side, and lower surface side of the 1st holding | maintenance unit 11 can be covered, it can prevent that an operator's finger is pinched or caught.
 なお、第5実施形態の操作部519は、撹拌ユニット13上方に延在するポールによって支持されたタッチパネルである。そして、タッチパネル519には、注入状況が表示される。また、オペレーターは、タッチパネル519を操作してインジェクターヘッド1を動作させることができる。 Note that the operation unit 519 of the fifth embodiment is a touch panel supported by a pole extending above the stirring unit 13. The touch panel 519 displays the injection status. Further, the operator can operate the injector head 1 by operating the touch panel 519.
 第5実施形態においても、シリンジを固定し且つ保持する保持ユニットを撹拌ユニットにより揺動することによって、シリンジ内の薬液が攪拌される。つまり、シリンジは、保持ユニットに固定された状態で保持ユニットと共に揺動する。これにより、撹拌動作を行っても、シリンジがずれてしまうことを防止できる。また、シリンジの取り付け及び取り外しは容易であり、撹拌ユニットを交換せずに、安価且つ容易に異なる種類のシリンジを装着することができる。さらに、シリンジの先端部分の近傍には保持部材が配置されていない。そのため、シリンジの先端部分が清潔な状態に維持される。なお、支持部材の配置場所は、第1保持ユニット11の先端側を避けていればよく、第1保持ユニット11の後端側には限定されない。 Also in the fifth embodiment, the chemical solution in the syringe is stirred by swinging the holding unit that fixes and holds the syringe by the stirring unit. That is, the syringe swings together with the holding unit while being fixed to the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean. In addition, the arrangement | positioning location of a supporting member should just avoid the front end side of the 1st holding unit 11, and is not limited to the rear end side of the 1st holding unit 11. FIG.
[第6実施形態]
 次に、図10乃至12を参照して第6実施形態に係るインジェクターに付いて説明する。第1実施形態のインジェクターでは、撹拌ユニット13が第1保持ユニット11の後端側に設けられていた。しかし、第6実施形態のインジェクターでは、撹拌ユニット13が第1保持ユニット11の先端側に設けられている。なお、第6実施形態の説明においては、第1実施形態との相違点について説明し、第1実施形態で説明した構成要素については同じ参照番号を付し、その説明を省略する。特に説明した場合を除き、同じ参照符号を付した構成要素は略同一の動作及び機能を奏し、その作用効果も略同一である。
[Sixth Embodiment]
Next, an injector according to a sixth embodiment will be described with reference to FIGS. In the injector of the first embodiment, the stirring unit 13 is provided on the rear end side of the first holding unit 11. However, in the injector of the sixth embodiment, the stirring unit 13 is provided on the distal end side of the first holding unit 11. Note that in the description of the sixth embodiment, differences from the first embodiment will be described, the same reference numerals will be given to the components described in the first embodiment, and description thereof will be omitted. Except where specifically described, the constituent elements having the same reference numerals perform substantially the same operations and functions, and the effects thereof are also substantially the same.
 第1実施形態と同様に、インジェクターヘッド1には、第1保持ユニット11、第2保持ユニット12、及び撹拌ユニット13が設けられている。撹拌ユニット13内には、支持部材としての支持アーム14(不図示)が配置されている。そして、第1保持ユニット11は、支持アーム14と支持アーム15とによって支持されている。一方、第1実施形態とは異なり、撹拌ユニット13と第2保持ユニット12とを収容するカバーは一体的に構成されている。そして、撹拌ユニット13は、第1保持ユニット11の先端側に配置されている。すなわち、第1保持ユニット11の先端側は、不図示のシャフト141を介して撹拌ユニット13の伝達機構131に接続されている。また、カバーに収容された制御部18が、第1保持ユニット11、第2保持ユニット12、及び撹拌ユニット13とヒンジを介して接続されている。さらに、操作部19が、制御部18上に配置されている。 As in the first embodiment, the injector head 1 is provided with a first holding unit 11, a second holding unit 12, and a stirring unit 13. A support arm 14 (not shown) as a support member is disposed in the stirring unit 13. The first holding unit 11 is supported by the support arm 14 and the support arm 15. On the other hand, unlike the first embodiment, the cover that accommodates the stirring unit 13 and the second holding unit 12 is integrally formed. The stirring unit 13 is disposed on the distal end side of the first holding unit 11. That is, the distal end side of the first holding unit 11 is connected to the transmission mechanism 131 of the stirring unit 13 via a shaft 141 (not shown). Moreover, the control part 18 accommodated in the cover is connected to the 1st holding | maintenance unit 11, the 2nd holding | maintenance unit 12, and the stirring unit 13 via the hinge. Further, the operation unit 19 is disposed on the control unit 18.
 また、第1シリンジ4が第1保持ユニット11から突出しないように、第1保持ユニット11の長さは第1シリンジ4よりも長い。そのため、第1シリンジ4が支持アーム14又は撹拌ユニット13に接触するおそれがない。これにより、撹拌動作の自由度を高めることができる。したがって、第6実施形態の撹拌動作は、第1保持ユニット11を一方向へ所定の時間回転させるように行うことができる。また、撹拌動作は、以下のように行うこともできる。まず、第1保持ユニット11を一方向へ180度揺動させる。すなわち、第1保持ユニット11の第1シリンジ4を装着する側が下を向く位置まで、第1保持ユニット11を揺動させる。その後、第1保持ユニット11を逆方向へ360度揺動させる。すなわち、元の位置を通過して第1シリンジ4を装着する側が下を向く位置まで、第1保持ユニット11を逆方向に揺動させる。なお、撹拌動作は、第1実施形態と同様に行うこともできる。 Also, the length of the first holding unit 11 is longer than that of the first syringe 4 so that the first syringe 4 does not protrude from the first holding unit 11. Therefore, there is no possibility that the first syringe 4 contacts the support arm 14 or the stirring unit 13. Thereby, the freedom degree of stirring operation can be raised. Therefore, the stirring operation of the sixth embodiment can be performed so as to rotate the first holding unit 11 in one direction for a predetermined time. Moreover, stirring operation can also be performed as follows. First, the first holding unit 11 is swung 180 degrees in one direction. That is, the first holding unit 11 is swung to a position where the side on which the first syringe 4 of the first holding unit 11 is attached faces downward. Thereafter, the first holding unit 11 is swung 360 degrees in the reverse direction. That is, the first holding unit 11 is swung in the reverse direction until it passes through the original position and the side on which the first syringe 4 is mounted faces downward. The stirring operation can be performed in the same manner as in the first embodiment.
 第6実施形態の撹拌ユニット13も、撹拌用モーター130と伝達機構131とを有する。そして、撹拌用モーター130からの回転運動は、出力軸を介して伝達機構131の第1ギア132に伝達される。第1ギア132が出力軸の回転に従い回転すると、第2ギア133、第3ギア134、及びベルト136を介して、第4ギア135が回転する。ここで、第4ギア135にはシャフト141が固定されているため、第4ギア135の回転に従いシャフト141が回転する。シャフト141は第1保持ユニット11の先端部材114に固定されているため、シャフト141の回転に従い第1保持ユニット11が揺動する。なお、撹拌用モーター130の出力軸は、シャフト141に直接接続させることもできる。 The stirring unit 13 of the sixth embodiment also includes a stirring motor 130 and a transmission mechanism 131. The rotational motion from the stirring motor 130 is transmitted to the first gear 132 of the transmission mechanism 131 via the output shaft. When the first gear 132 rotates according to the rotation of the output shaft, the fourth gear 135 rotates via the second gear 133, the third gear 134, and the belt 136. Here, since the shaft 141 is fixed to the fourth gear 135, the shaft 141 rotates according to the rotation of the fourth gear 135. Since the shaft 141 is fixed to the tip member 114 of the first holding unit 11, the first holding unit 11 swings as the shaft 141 rotates. The output shaft of the stirring motor 130 can be directly connected to the shaft 141.
 図11及び12に示すように、オペレーターは、撹拌動作を行う前に第1シリンジ4及び第2シリンジ5を所定の角度で傾ける。すなわち、手動で第1保持ユニット11及び第2保持ユニット12を注入位置まで傾ける。そして、第1保持ユニット11及び第2保持ユニット12は、傾いた状態で不図示のロック手段により固定される。このように、第1シリンジ4が傾いた状態で撹拌動作が行われる。具体的には、図11に示すように、第1保持ユニット11を一方向へ所定の角度だけ揺動させる。その後、図12に示すように、元の位置を通過して第1保持ユニット11を逆方向へ所定の角度だけ揺動させる。これにより、第1保持ユニット11に固定され且つ保持された第1シリンジ4内の造影剤が撹拌される。なお、第1保持ユニット11及び第2保持ユニット12を傾けるために、リフターを設けることもできる。この場合、オペレーターは操作部19を操作し、リフターによって第1保持ユニット11及び第2保持ユニット12を持ち上げる。これにより、第1保持ユニット11及び第2保持ユニット12を、自動的に傾けることができる。 11 and 12, the operator tilts the first syringe 4 and the second syringe 5 at a predetermined angle before performing the stirring operation. That is, the first holding unit 11 and the second holding unit 12 are manually tilted to the injection position. And the 1st holding | maintenance unit 11 and the 2nd holding | maintenance unit 12 are fixed by the locking means not shown in the state which inclined. In this way, the stirring operation is performed with the first syringe 4 tilted. Specifically, as shown in FIG. 11, the first holding unit 11 is swung by a predetermined angle in one direction. Thereafter, as shown in FIG. 12, the first holding unit 11 is swung in the reverse direction by a predetermined angle through the original position. Thereby, the contrast agent in the 1st syringe 4 fixed and hold | maintained at the 1st holding | maintenance unit 11 is stirred. In addition, in order to incline the 1st holding | maintenance unit 11 and the 2nd holding | maintenance unit 12, a lifter can also be provided. In this case, the operator operates the operation unit 19 and lifts the first holding unit 11 and the second holding unit 12 with a lifter. Thereby, the 1st holding | maintenance unit 11 and the 2nd holding | maintenance unit 12 can be inclined automatically.
 第6実施形態においても、シリンジを固定し且つ保持する保持ユニットを撹拌ユニットにより揺動することによって、シリンジ内の薬液が攪拌される。つまり、シリンジは、保持ユニットに固定された状態で保持ユニットと共に揺動する。これにより、撹拌動作を行っても、シリンジがずれてしまうことを防止できる。また、シリンジの取り付け及び取り外しは容易であり、撹拌ユニットを交換せずに、安価且つ容易に異なる種類のシリンジを装着することができる。さらに、シリンジの先端部分の近傍には保持部材が配置されていない。そのため、シリンジの先端部分が清潔な状態に維持される。 Also in the sixth embodiment, the chemical solution in the syringe is stirred by swinging the holding unit that fixes and holds the syringe by the stirring unit. That is, the syringe swings together with the holding unit while being fixed to the holding unit. Thereby, even if stirring operation is performed, it can prevent that a syringe will shift. Moreover, the attachment and removal of the syringe are easy, and different types of syringes can be attached inexpensively and easily without replacing the stirring unit. Further, no holding member is disposed in the vicinity of the distal end portion of the syringe. Therefore, the tip portion of the syringe is kept clean.
[第7実施形態]
 次に、図13を参照して第7実施形態に係る薬液の注入システムに付いて説明する。第7実施形態の薬液注入システムにおいては、撹拌動作の履歴を記録した履歴データを外部記憶手段700に記憶させることができる。なお、第7実施形態の説明においては、第1実施形態との相違点について説明し、第1実施形態で説明した構成要素については同じ参照番号を付し、その説明を省略する。特に説明した場合を除き、同じ参照符号を付した構成要素は略同一の動作及び機能を奏し、その作用効果も略同一である。
[Seventh Embodiment]
Next, a chemical solution injection system according to a seventh embodiment will be described with reference to FIG. In the chemical solution injection system of the seventh embodiment, history data in which the history of the stirring operation is recorded can be stored in the external storage unit 700. Note that in the description of the seventh embodiment, differences from the first embodiment will be described, and the same reference numerals will be given to the components described in the first embodiment, and description thereof will be omitted. Except where specifically described, the constituent elements having the same reference numerals perform substantially the same operations and functions, and the effects thereof are also substantially the same.
 薬液注入システムは、薬液を注入する注入装置としてのインジェクター100と、インジェクター100と通信し且つ患者情報(カルテ情報)等を記憶する、データベースサーバー又は病院内情報システム等の外部記憶手段700とを備える。さらに、薬液注入システムは、超音波診断装置等の医療用撮影装置800を備えることもできる。また、インジェクター100のインジェクターヘッド1には、制御部18、操作部19、通信部71、及びRFIDリーダ72が設けられている。また、第1シリンジ4には、RFIDチップ73が設けられている。そして、RFIDチップ73には、少なくとも注入される薬液に関連する薬液データが記憶されている。当該データは、例えば、薬液の名称又はID、粘度、消費期限、シリンジ容量、ロット番号等のデータを含む。なお、RFIDチップ73には、インジェクターヘッド1等が後からデータを記憶させることもできる。RFIDリーダ72は、第1シリンジ4が第1保持ユニット11に正しく装着されたときのみ、RFIDチップ73と無線通信できる位置に設けられている。 The chemical solution injection system includes an injector 100 as an injection device for injecting a chemical solution, and an external storage unit 700 such as a database server or an in-hospital information system that communicates with the injector 100 and stores patient information (medical chart information) and the like. . Furthermore, the chemical liquid injection system can also include a medical imaging apparatus 800 such as an ultrasonic diagnostic apparatus. The injector head 1 of the injector 100 is provided with a control unit 18, an operation unit 19, a communication unit 71, and an RFID reader 72. The first syringe 4 is provided with an RFID chip 73. The RFID chip 73 stores at least chemical liquid data related to the chemical liquid to be injected. The data includes, for example, data such as the name or ID of the chemical solution, viscosity, expiration date, syringe capacity, lot number, and the like. The RFID chip 73 can also store data later by the injector head 1 or the like. The RFID reader 72 is provided at a position where it can wirelessly communicate with the RFID chip 73 only when the first syringe 4 is correctly attached to the first holding unit 11.
 オペレーターが操作部19から患者の体重等の注入条件データを入力すると、制御部18は注入条件データを受信する。また、制御部18は、RFIDリーダ72によりRFIDチップ73から薬液データを取得する。そして、制御部18は、注入条件データ及び薬液データから注入プロトコルを算出する。また、制御部18は、通信部71を介して外部記憶手段700から注入条件データ又は注入プロトコルを取得することもできる。制御部18は、注入プロトコルに従い第1駆動部16及び第2駆動部17を制御し、注入動作を行わせる。さらに、制御部18は、前述した様に撹拌ユニット13を制御し、撹拌動作を行わせる。 When the operator inputs injection condition data such as the patient's weight from the operation unit 19, the control unit 18 receives the injection condition data. In addition, the control unit 18 acquires chemical liquid data from the RFID chip 73 by the RFID reader 72. And the control part 18 calculates an injection | pouring protocol from injection | pouring condition data and chemical | medical solution data. The control unit 18 can also acquire injection condition data or an injection protocol from the external storage unit 700 via the communication unit 71. The control unit 18 controls the first driving unit 16 and the second driving unit 17 according to the injection protocol to perform the injection operation. Furthermore, the control part 18 controls the stirring unit 13 as mentioned above, and performs stirring operation.
 また、制御部18は、注入動作及び撹拌動作の履歴を記録した履歴データを生成する。そして、制御部18は、履歴データを外部記憶手段700に送信し、患者に対応するカルテ情報に記録させることができる。撹拌動作の履歴データには、薬液の名称、撹拌時間、揺動速度等のデータが含まれ得る。また、注入動作の履歴データには、薬液の名称、注入時間、注入速度等のデータが含まれ得る。なお、制御部18は、通信部を介して超音波診断装置から画像に関するデータ、例えばID、撮影時間又は撮影部位等のデータを取得することもできる。そして、制御部18は、履歴データを画像と関連付けた状態で外部記憶手段700に記憶させることができる。また、オペレーターは、病院内情報システムの端末を利用してインジェクター100に注入プロトコル等の情報を送受信することができる。 Further, the control unit 18 generates history data that records the history of the injection operation and the stirring operation. And the control part 18 can transmit historical data to the external memory | storage means 700, and can record it on the medical chart information corresponding to a patient. The history data of the stirring operation may include data such as the name of the chemical solution, the stirring time, and the rocking speed. Further, the history data of the injection operation may include data such as the name of the chemical solution, the injection time, and the injection speed. Note that the control unit 18 can also acquire data relating to an image, for example, data such as an ID, an imaging time, or an imaging region, from the ultrasonic diagnostic apparatus via the communication unit. And the control part 18 can memorize | store the historical data in the external memory | storage means 700 in the state linked | related with the image. The operator can send and receive information such as an injection protocol to the injector 100 using a terminal of the in-hospital information system.
 第7実施形態においては、インジェクター100が、外部機器と通信を行う通信部71を備える。これにより、インジェクター100は、超音波診断装置等の医療用撮影装置800、又はデータベースサーバー等の外部記憶手段700と情報の送受信を行うことができる。また、RFIDチップ73を有するシリンジを用いることにより、薬液データ等を超音波診断装置800又は外部記憶手段700に送信して、記憶させることも可能である。インジェクター100は、注入動作及び撹拌動作の履歴を記録した履歴データを外部記憶手段700に送信する、又は外部記憶手段700から薬液の注入プロトコル等を受信することもできる。さらに、外部記憶手段700から患者の体重等の情報を受信して、インジェクター100の制御部18において注入プロトコルを算出することもできる。このように、インジェクター100と、患者情報を記憶した外部記憶手段700とを連携させることにより、適切な撮影を行うことができる。また、医療用撮影装置800を連携させることにより、造影剤注入後の適切なタイミングで撮像を行うこともできる。 In the seventh embodiment, the injector 100 includes a communication unit 71 that communicates with an external device. Thereby, the injector 100 can transmit / receive information to / from the medical imaging apparatus 800 such as an ultrasonic diagnostic apparatus or the external storage unit 700 such as a database server. In addition, by using a syringe having the RFID chip 73, it is possible to transmit the medicinal solution data or the like to the ultrasonic diagnostic apparatus 800 or the external storage unit 700 for storage. The injector 100 can transmit history data in which the history of the injection operation and the agitation operation is recorded to the external storage unit 700, or can receive a chemical injection protocol or the like from the external storage unit 700. Furthermore, information such as the weight of the patient can be received from the external storage means 700 and the injection protocol can be calculated by the control unit 18 of the injector 100. Thus, appropriate imaging can be performed by linking the injector 100 and the external storage unit 700 that stores patient information. Further, by linking the medical imaging apparatus 800, it is possible to perform imaging at an appropriate timing after the injection of the contrast medium.
 以上、実施例を参照して本発明について説明したが、本発明は上記実施例に限定されるものではない。本発明に反しない範囲で変更された発明、及び本発明と均等な発明も本発明に含まれる。また、上述の各実施形態及び変形例は、本発明に反しない範囲で適宜組み合わせることができる。 The present invention has been described above with reference to the embodiments, but the present invention is not limited to the above embodiments. Inventions modified within the scope not departing from the present invention and inventions equivalent to the present invention are also included in the present invention. Moreover, each above-mentioned embodiment and modification can be combined suitably in the range which is not contrary to this invention.
 例えば、撹拌ユニット13の伝達機構131を省略して、撹拌用モーター130の出力軸がシャフト151に接続されてもよい。また、駆動部は、ステッピングモーターに代えて、超音波モーターを有することもできる。さらに、第2保持ユニット12は固定されていたが、第1保持ユニット11と同様に揺動させることもできる。なお、第1実施形態においても、第1保持ユニット11と撹拌ユニット13又は支持アーム15とを離間させることができる。また、第1保持ユニット11と支持アーム14とを離間させることもできる。これにより、オペレーターの指が誤って挟まれる又は揺動に巻き込まれることを防止できる。さらに、第5実施形態以外の実施形態においても、第1保持ユニット11を透明なカバーで覆うことができる。 For example, the transmission mechanism 131 of the stirring unit 13 may be omitted, and the output shaft of the stirring motor 130 may be connected to the shaft 151. Further, the drive unit may have an ultrasonic motor instead of the stepping motor. Further, although the second holding unit 12 is fixed, it can be swung in the same manner as the first holding unit 11. Also in the first embodiment, the first holding unit 11 and the stirring unit 13 or the support arm 15 can be separated. Moreover, the 1st holding | maintenance unit 11 and the support arm 14 can also be spaced apart. Thereby, it is possible to prevent the operator's finger from being accidentally pinched or involved in swinging. Furthermore, also in embodiments other than the fifth embodiment, the first holding unit 11 can be covered with a transparent cover.
 また、第1実施形態において、第2保持ユニット12に、第2シリンジ5の外面に接触するヒーター(不図示)をさらに設けてもよい。ヒーターは、第2保持ユニット12に設けられたシリンダ受け部120に設けられ、第2シリンジ5のシリンダ52を加熱又は保温する。このヒーターは、シリンダ受け部120上面に配置されるか、又はシリンダ受け部120に内蔵される。ヒーターによって生理食塩水を保温することにより、所定の温度、例えば人間の体温程度の温度を維持することができる。 In the first embodiment, the second holding unit 12 may further be provided with a heater (not shown) that contacts the outer surface of the second syringe 5. The heater is provided in a cylinder receiving portion 120 provided in the second holding unit 12 and heats or keeps the cylinder 52 of the second syringe 5. This heater is arranged on the upper surface of the cylinder receiving part 120 or is built in the cylinder receiving part 120. By maintaining the physiological saline with a heater, a predetermined temperature, for example, a temperature about the human body temperature can be maintained.
 この出願は2012年4月12日に出願された日本国特許出願第2012-091256号からの優先権を主張するものであり、その内容を引用してこの出願の一部とするものである。 This application claims priority from Japanese Patent Application No. 2012-091256 filed on April 12, 2012, the contents of which are incorporated herein by reference.
  1:インジェクターヘッド、2:スタンド、4:第1シリンジ、5:第2シリンジ、6:シリンジアダプタ、9:チューブ、11:第1保持ユニット、12:第2保持ユニット、13:撹拌ユニット、14:支持アーム、15:支持アーム、16:第1駆動部、17:第2駆動部、18:制御部、19:操作部、41:シリンダフランジ、42:シリンダ、43:導管部、44:ピストン、51:シリンダフランジ、52:シリンダ、53:導管部、54:ピストン、71:通信部、72:RFIDリーダ、73:RFIDチップ、91:第1チューブ、92:第2チューブ、93:第1コネクター、94:第2コネクター、95:先端部、96:リリースバルブ、100:インジェクター、110:シリンダ受け部、114:先端部材、115:後端部材、116:梁部材、120:シリンダ受け部、130:撹拌用モーター、131:伝達機構、132:第1ギア、133:第2ギア、134:第3ギア、135:第4ギア、136:ベルト、141:シャフト、151:シャフト、152:シャフト、160:プレッサー、161:注入用モーター、162:変換機構、163:ボールねじ、164:係合部、165:ガイドシャフト、170:プレッサー、171:注入用モーター、172:変換機構、173:ボールねじ、174:係合部、175:ガイドシャフト、216:ビーム、217:ビーム、241:シャフト、251:シャフト、314:先端部材、315:後端部材、316:梁部材、317:スライドシャフト、318:カバー、331:リンク機構、332:ディスク、333:ロッド、334:スライダ、430:振動ボックス、431:揺動アーム、519:操作部、700:外部記憶手段、800:医療用撮影装置 1: injector head, 2: stand, 4: first syringe, 5: second syringe, 6: syringe adapter, 9: tube, 11: first holding unit, 12: second holding unit, 13: stirring unit, 14 : Support arm, 15: support arm, 16: first drive unit, 17: second drive unit, 18: control unit, 19: operation unit, 41: cylinder flange, 42: cylinder, 43: conduit unit, 44: piston 51: cylinder flange, 52: cylinder, 53: conduit section, 54: piston, 71: communication section, 72: RFID reader, 73: RFID chip, 91: first tube, 92: second tube, 93: first Connector: 94: Second connector, 95: Tip portion, 96: Release valve, 100: Injector, 110: Cylinder receiving portion, 114: Tip member 115: Rear end member, 116: Beam member, 120: Cylinder receiving portion, 130: Motor for stirring, 131: Transmission mechanism, 132: First gear, 133: Second gear, 134: Third gear, 135: Fourth Gear: 136: Belt, 141: Shaft, 151: Shaft, 152: Shaft, 160: Presser, 161: Motor for injection, 162: Conversion mechanism, 163: Ball screw, 164: Engagement part, 165: Guide shaft, 170 : Presser, 171: Motor for injection, 172: Conversion mechanism, 173: Ball screw, 174: Engagement part, 175: Guide shaft, 216: Beam, 217: Beam, 241: Shaft, 251: Shaft, 314: Tip member 315: Rear end member, 316: Beam member, 317: Slide shaft, 318: Cover, 331: Link mechanism 332: Disc 333: Rod 334: Slider 430: Vibration box 431: Swing arm 519: Operation unit 700: External storage means 800: Medical imaging apparatus

Claims (15)

  1.  薬液を注入する注入装置であって、
     第1薬液が充填された第1シリンジから前記第1薬液を押し出す第1駆動部と、
     前記第1シリンジを固定し且つ保持する第1保持ユニットと、
     前記第1保持ユニットを支持する支持部材と、
     前記第1保持ユニットに接続されると共に、前記第1シリンジ内の前記第1薬液を撹拌するために、前記第1保持ユニットを動かす撹拌ユニットとを備える、注入装置。
    An injection device for injecting a chemical solution,
    A first drive unit for pushing out the first chemical solution from the first syringe filled with the first chemical solution;
    A first holding unit for fixing and holding the first syringe;
    A support member for supporting the first holding unit;
    An injection device comprising: an agitation unit that is connected to the first holding unit and moves the first holding unit in order to agitate the first chemical solution in the first syringe.
  2.  前記撹拌ユニットは、撹拌用モーターと、前記撹拌用モーターからの回転力をシャフトに伝達する伝達機構とを有し、
     前記第1保持ユニットは、前記シャフトを介して前記伝達機構に接続されており、
     前記第1保持ユニットは、前記支持部材に対して前記シャフトを中心に揺動する、請求項1に記載の注入装置。
    The stirring unit includes a stirring motor and a transmission mechanism that transmits a rotational force from the stirring motor to a shaft,
    The first holding unit is connected to the transmission mechanism via the shaft,
    The injection device according to claim 1, wherein the first holding unit swings around the shaft with respect to the support member.
  3.  前記第1保持ユニットは、前記第1シリンジの軸線方向と交差する方向に揺動する、請求項2に記載の注入装置。 The injection device according to claim 2, wherein the first holding unit swings in a direction intersecting an axial direction of the first syringe.
  4.  前記第1保持ユニットは、前記第1シリンジの軸線方向に沿った方向に揺動する、請求項2に記載の注入装置。 The injection device according to claim 2, wherein the first holding unit swings in a direction along an axial direction of the first syringe.
  5.  前記撹拌ユニットは、撹拌用モーターと、前記撹拌用モーターに接続されたリンク機構とを有し、
     前記第1保持ユニットは、前記リンク機構に接続されており、
     前記第1保持ユニットは、前記第1シリンジの軸線方向に沿った方向に摺動する、請求項1に記載の注入装置。
    The stirring unit has a stirring motor and a link mechanism connected to the stirring motor,
    The first holding unit is connected to the link mechanism;
    The injection device according to claim 1, wherein the first holding unit slides in a direction along an axial direction of the first syringe.
  6.  第2薬液が充填された第2シリンジから前記第2薬液を押し出す第2駆動部と、
     前記第2シリンジを固定し且つ保持する第2保持ユニットとをさらに備え、
     前記第2保持ユニットは、前記支持部材に固定され且つ保持される、請求項1乃至5のいずれか1項に記載の注入装置。
    A second drive unit for extruding the second chemical liquid from the second syringe filled with the second chemical liquid;
    A second holding unit for fixing and holding the second syringe;
    The injection device according to any one of claims 1 to 5, wherein the second holding unit is fixed and held on the support member.
  7.  前記駆動部を制御する制御部を備え、
     前記制御部は、前記第1保持ユニットが停止した後に前記薬液の注入を開始する、請求項1乃至6のいずれか1項に記載の注入装置。
    A control unit for controlling the drive unit;
    The injection device according to any one of claims 1 to 6, wherein the controller starts injecting the chemical solution after the first holding unit is stopped.
  8.  前記第1保持ユニットは、前記第1シリンジの外面に接触するヒーターを有する、請求項1乃至7のいずれか1項に記載の注入装置。 The injection device according to any one of claims 1 to 7, wherein the first holding unit includes a heater that contacts an outer surface of the first syringe.
  9.  前記支持部材は、前記第1保持ユニットの先端側を避けて配置されている、請求項1乃至8のいずれか1項に記載の注入装置。 The injection device according to any one of claims 1 to 8, wherein the support member is disposed so as to avoid a tip side of the first holding unit.
  10.  前記撹拌ユニットは、前記第1保持ユニットの先端側に配置されている、請求項1乃至3のいずれか1項に記載の注入装置。 The injection device according to any one of claims 1 to 3, wherein the agitation unit is disposed on a distal end side of the first holding unit.
  11.  薬液を注入する注入装置であって、
     薬液が充填されたシリンジから前記薬液を押し出す駆動部と、
     前記シリンジを固定し且つ保持する保持ユニットと、
     前記保持ユニットを支持する支持部材と、
     前記保持ユニットから離間した位置において前記シリンジの外面に接触すると共に、前記シリンジ内の前記薬液を撹拌するために、前記シリンジを動かす撹拌ユニットとを備える、注入装置。
    An injection device for injecting a chemical solution,
    A drive unit for extruding the chemical solution from a syringe filled with the chemical solution;
    A holding unit for fixing and holding the syringe;
    A support member for supporting the holding unit;
    An infusion apparatus comprising: an agitation unit that contacts the outer surface of the syringe at a position spaced from the holding unit and moves the syringe to agitate the drug solution in the syringe.
  12.  前記撹拌ユニットは、振動モーターを有し、前記シリンジの上面に接触して前記シリンジに振動を加える、請求項11に記載の注入装置。 The injection device according to claim 11, wherein the agitation unit has a vibration motor, and contacts the upper surface of the syringe to apply vibration to the syringe.
  13.  薬液の流れる方向を自動で切り替えるように、三方活栓をさらに備える、請求項1乃至12のいずれか1項に記載の注入装置。 The injection device according to any one of claims 1 to 12, further comprising a three-way stopcock so as to automatically switch a flowing direction of the chemical solution.
  14.  薬液の分離を検知するセンサーをさらに備える、請求項1乃至13のいずれか1項に記載の注入装置。 The injection device according to any one of claims 1 to 13, further comprising a sensor that detects separation of the chemical solution.
  15.  請求項1乃至14のいずれか1項に記載の注入装置と、前記注入装置と通信する外部記憶手段とを備える薬液の注入システムであって、
     前記注入装置は、前記外部記憶手段と通信を行うための通信部を備える、注入システム。
    A chemical solution injection system comprising: the injection device according to any one of claims 1 to 14; and an external storage means that communicates with the injection device.
    The infusion system includes an infusion system including a communication unit for communicating with the external storage unit.
PCT/JP2013/002458 2012-04-12 2013-04-11 Agitating injection device WO2013153812A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2014510058A JP6463628B2 (en) 2012-04-12 2013-04-11 Stirring injection device
CN201380019290.8A CN104220110A (en) 2012-04-12 2013-04-11 Agitating injection device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012091256 2012-04-12
JP2012-091256 2012-04-12

Publications (1)

Publication Number Publication Date
WO2013153812A1 true WO2013153812A1 (en) 2013-10-17

Family

ID=49327396

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/002458 WO2013153812A1 (en) 2012-04-12 2013-04-11 Agitating injection device

Country Status (3)

Country Link
JP (1) JP6463628B2 (en)
CN (1) CN104220110A (en)
WO (1) WO2013153812A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015141202A1 (en) * 2014-03-17 2015-09-24 株式会社根本杏林堂 Injection device and device for controlling injection device
JP2016140691A (en) * 2015-02-05 2016-08-08 公立大学法人奈良県立医科大学 Syringe rotation device
WO2017179345A1 (en) * 2016-04-14 2017-10-19 株式会社根本杏林堂 Injector
CN113398364A (en) * 2021-07-21 2021-09-17 胡春 Cardiovascular internal medicine contrast agent injector
US20210338925A1 (en) * 2018-07-13 2021-11-04 Aptar France Sas Fluid product injection device
WO2023181578A1 (en) * 2022-03-24 2023-09-28 テルモ株式会社 Inflation/deflation device and inflation/deflation system

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106345010B (en) * 2016-08-24 2019-08-23 吉林省农业科学院 A kind of animal injection device with store function
JP6938019B2 (en) * 2017-07-27 2021-09-22 株式会社根本杏林堂 Detachable device and multiple injection device
CN108593789B (en) * 2018-04-10 2020-11-27 浙江程诚文化用品有限公司 Paste and apply type medical product cutting system liquid device
JP7144465B2 (en) * 2020-01-20 2022-09-29 ディーブイエックス株式会社 Contrast injection device and injection line kit
CN113509607B (en) * 2021-04-23 2023-04-18 温州医科大学附属第一医院 Pulmonary artery high-pressure cardiac hybrid radiography auxiliary device
CN118139662A (en) * 2022-08-05 2024-06-04 苏州恒瑞宏远医疗科技有限公司 Remote control device, remote system, injector, slave system and injection system

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002301147A (en) * 2001-04-05 2002-10-15 Fujisawa Pharmaceut Co Ltd Supernatant liquid sampling apparatus equipped with balance weight forming function
JP2004290455A (en) * 2003-03-27 2004-10-21 Nemoto Kyorindo:Kk Method and apparatus for injecting chemical
JP2004313579A (en) * 2003-04-18 2004-11-11 Nemoto Kyorindo:Kk Medical fluid filling device
JP2005534446A (en) * 2002-08-07 2005-11-17 アメルシャム ヘルス アクスイェ セルスカプ Syringe adapter with a driver for stirring the contents of the syringe
JP2009279438A (en) * 2002-07-02 2009-12-03 Panasonic Corp Medical automatic administration instrument
JP2010063767A (en) * 2008-09-12 2010-03-25 K & Y:Kk Infusion pump system
JP2011067265A (en) * 2009-09-24 2011-04-07 Sun Medical Co Ltd Prefilled syringe and composite prefilled syringe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19840532A1 (en) * 1998-08-28 2000-03-09 Schering Ag Syringe filled with ultrasound contrast medium with a mechanical movement device
US6575930B1 (en) * 1999-03-12 2003-06-10 Medrad, Inc. Agitation devices and dispensing systems incorporating such agitation devices
US6709378B2 (en) * 2001-04-05 2004-03-23 Fujisawa Pharmaceutical Co., Ltd. Supernatant liquid collector with balance weight forming function and centrifugal apparatus using the same
JP2004065736A (en) * 2002-08-08 2004-03-04 Nemoto Kyorindo:Kk Liquid medicine injection apparatus
WO2006054651A1 (en) * 2004-11-18 2006-05-26 Nemoto Kyorindo Co., Ltd. Chemical liquid infusion system

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002301147A (en) * 2001-04-05 2002-10-15 Fujisawa Pharmaceut Co Ltd Supernatant liquid sampling apparatus equipped with balance weight forming function
JP2009279438A (en) * 2002-07-02 2009-12-03 Panasonic Corp Medical automatic administration instrument
JP2005534446A (en) * 2002-08-07 2005-11-17 アメルシャム ヘルス アクスイェ セルスカプ Syringe adapter with a driver for stirring the contents of the syringe
JP2004290455A (en) * 2003-03-27 2004-10-21 Nemoto Kyorindo:Kk Method and apparatus for injecting chemical
JP2004313579A (en) * 2003-04-18 2004-11-11 Nemoto Kyorindo:Kk Medical fluid filling device
JP2010063767A (en) * 2008-09-12 2010-03-25 K & Y:Kk Infusion pump system
JP2011067265A (en) * 2009-09-24 2011-04-07 Sun Medical Co Ltd Prefilled syringe and composite prefilled syringe

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015141202A1 (en) * 2014-03-17 2015-09-24 株式会社根本杏林堂 Injection device and device for controlling injection device
JPWO2015141202A1 (en) * 2014-03-17 2017-04-06 株式会社根本杏林堂 INJECTION DEVICE AND INJECTION DEVICE CONTROL DEVICE
JP2016140691A (en) * 2015-02-05 2016-08-08 公立大学法人奈良県立医科大学 Syringe rotation device
WO2017179345A1 (en) * 2016-04-14 2017-10-19 株式会社根本杏林堂 Injector
JPWO2017179345A1 (en) * 2016-04-14 2019-02-28 株式会社根本杏林堂 Injection device
US20210338925A1 (en) * 2018-07-13 2021-11-04 Aptar France Sas Fluid product injection device
CN113398364A (en) * 2021-07-21 2021-09-17 胡春 Cardiovascular internal medicine contrast agent injector
CN113398364B (en) * 2021-07-21 2022-12-20 深圳安中医学科技有限公司 Cardiovascular internal medicine contrast agent injector
WO2023181578A1 (en) * 2022-03-24 2023-09-28 テルモ株式会社 Inflation/deflation device and inflation/deflation system

Also Published As

Publication number Publication date
JP6463628B2 (en) 2019-02-06
JPWO2013153812A1 (en) 2015-12-17
CN104220110A (en) 2014-12-17

Similar Documents

Publication Publication Date Title
JP6463628B2 (en) Stirring injection device
CN1306992C (en) Syringe adapter with a driver for agitation of the syringe content
JP6817644B2 (en) Injection device and control device for injection device
ES2386917T3 (en) Motorized injector with pusher retraction
EP1016427B1 (en) A method and device for filing a syringe with a chemical solution
JP2004358047A (en) Medical liquid injecting system
US7331938B2 (en) Medicine liquid injection device where medicine liquid sucked up from medicine liquid tank and injected to subject does not flow back
WO2005002650A1 (en) Chemical liquid injection system detecting attachment and detachment of chemical liquid syringe to and from chemical liquid injection device
US20050148868A1 (en) Contrast container holder and method to fill syringes
WO2008007674A1 (en) Chemical liquid loading device
JP6235080B2 (en) X-ray CT system, chemical injection device and CT scanner
CN115670629A (en) Bone cement injection robot
CN209884933U (en) Double-cylinder high-pressure radiography syringe
JPWO2008126854A1 (en) Chemical injection device
JP2004194877A (en) Medicinal liquid injection system
WO2006132146A1 (en) Cylinder adapter
JP2009039310A (en) Medical solution filling device
JP2004121467A (en) Medical fluid injection apparatus
JP5329156B2 (en) Chemical injection device and system provided with the same
CN219742721U (en) Radioactive source preparation device
JP4119224B2 (en) Chemical injection device
JP2004187849A (en) Medical solution feeder
JP2005021495A (en) Fluoroscopic image pick-up system
JP6912068B2 (en) Injection device
JP2004290454A (en) Chemical injector

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13775456

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2014510058

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13775456

Country of ref document: EP

Kind code of ref document: A1